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CHAPTER I 
INTRODUCTION AND REVIEW OF RELATED LITERATURE 
Research interest has recently developed for a 
heterogeneous group of chemical compounds which have poten-
tial therapeutic usefulness as antimicrobial agents due to 
their capacity to augment responses of lymphocytes and 
macrophages. These compounds have been termed "pro-host" 
(40) because, rather than being directly microbicidal, 
they enhance the antimicrobial activities of host defense 
cells. 
Included in such leukocyte-modulating substances 
are semi-synthetic or wholly synthetic agents such as 
muramyl dipeptide (MOP) (13,40), inosiplex (40,111) and 
levamisole (33,40). Another such agent is SM-1213 [1,2-0-
isopropylidene-3-0-3'-(N',N'-dimethylamino-n-propyl)-D-
glucofuranose, monohydrochloride], a synthetic, substituted 
monosaccharide which is reported to potentiate macrophage 
bactericidal activity (12,40). Recent studies describe 
antiviral, antitumor and immunomodulatory activities of 
SM-1213 (36,74), but few studies have examined for the 
effects of SM-1213 on an in vitro fungal infection of host 
phagocytes (83,84). 
1 
The present work examined for a potential enhan-
cing effect of SM-1213 on the fungistatic or fungicidal 
capacities of oil-elicited guinea pig peritoneal exudate 
cells (PEC-0) and for the mechanism of such an effect 
against both the yeast and the hypha! forms of Candida 
albicans, a clinically important dimorphic fungus (44). 
2 
Candida albicans is an opportunistic fungus in 
that it is commonly found as part of the normal flora of 
many mammals, including man. Diabetes, neoplasms, immuno-
logical defects and immunosuppressive therapy are factors 
which favor the pathogenic invasion of Candida and the 
development of systemic in~ection (34,105). Host resis-
tance to infection by ~ albicans involves specific cell-
mediated immune responses (54,55,68), as well as non-
specific host defense mechanisms (47,82,120) in which 
phagocytic cells predominate (106). 
Cell-mediated immunity (CMI) has been implicated 
as being of primary importance (54,55) in protection from 
the chronic mucocutaneous form of candidiasis (CMC). Pos-
itive therapeutic results were obtained after administra-
tion of a combination of antifungal antibiotics and injec-
tions of transfer factor or immunocompetent lymphocytes, 
suggesting a defect in thymus-dependent CMI in these pa-
tients (54,55). Candida! dissemination occurs rarely in 
CMC patients, however (58), and the mechanism whereby 
3 
candidal spread is prevented is not clear. For example, 
in congenitally athymic nude mice (108), resistance to 
experimental disseminated candidiasis was greater than 
that observed for their phenotypically normal littermates. 
Antibody-mediated immune responses were severely impaired 
and could not, therefore; account for the enhanced resis-
tance of the athyrnic mice (108). It was suggested that 
high levels of activated macrophages contributed to the 
observed effects (108). This suggestion, along with the 
observation that disseminated candidiasis occurs in pa-
tients with chronic granulomatous disease (CGD) or myelo-
peroxidase (MPO) deficiency, where the antimicrobial ca-
pacities of phagocytic cells are impaired (60,64), implies 
that neutrophils or activated macrophages play the most 
important role in host defense against systemic candidi-
asis (108). [For reviews, see (30,107).] It has also 
been suggested, however, that phagocytes may actually 
promote the establishment of renal candidiasis in thymus-
bearing mice (58). Therefore, in order to understand the 
critical role macrophages play in host resistance to can-
didiasis, several researchers have examined the capacity 
of mononuclear phagocytes to ingest and kill C. albicans 
in vitro (62,118,122). 
Conflicting information regarding the ability of 
cultured macrophages to destroy c. albicans has resulted 
4 
from the utilization of mononuclear cells derived from 
various sites, such as the blood (62), the peritoneum . 
(99,118) or alveoli (3,65), and from various animal species 
including mouse (118,122), man (62) and rabbit (3,65). 
Analysis is further complicated, since resident (118,122), 
elicited (99) or activated (65,118) macrophages have been 
employed under multiple culture conditions. Resident or 
normal macrophages and circulating blood monocytes are 
obtained from untreated animals, while elicited macrophages 
are derived from animals injected with an inflammatory 
stimulus, such as glycogen, thioglycollate, casein, pro-
teose peptone, mineral oiL, or a bacterial product such 
as lipopolysaccharide (LPS). Activated macrophages are 
obtained from animals vaccinated by injection of an agent 
such as bacillus Calmette-Guerin (BCG) or infected by 
intracellular parasites such as Mycobacterium or Listeria 
(48). During the later states of infection or after host 
recovery, activated macrophages possess an enhanced capac-
ity to kill the same or unrelated organisms (72), and 
display such characteristics as an increase in size, en-
hanced spreading, greater numbers of lysosomal granules 
and an increase in content of hydrolytic enzymes (17,53). 
Elicited macrophages share some, but not all, of these 
properties. [For a review of the biochemical aspects of 
mouse peritoneal macrophages in various physiological 
states as compared to resident macrophages, see Karnovsky 
and Lazdins (53).] The oxidative response of activated. 
and elicited macrophages to a phagocytic stimulus is also 
enhanced in these cells relative to resident macrophages. 
[For a review of the evidence that the phagocytosis-asso-
ciated oxidative burst is increased in elicited and acti-
vated macrophages, see Johnston (48).] 
5 
Production of reactive oxygen metabolites by macro-
phages mediates much of their microbicidal (50,118,127) and 
tumoricidal (92,97) activity, although some killing by oxy-
gen-independent mechanisms also occurs (66,67,86). Oxygen-
dependent systems are classified as such because of a de-
crease in microbicidal or tumoricidal activity under anaer-
obic conditions (63,81,97). However, some microbes (76), 
such as Bacteroides fragilis, Staphylococcus epidermidis 
and Clostridium perfringens, are normally killed by phago-
cytes in the absence of air. Therefore, oxygen-independent 
antimicrobial mechanisms must also exist. Possible media-
tors of macrophage oxygen-independent cytocidal activity 
include acid hydrolases (19,117), alkaline phosphatase (29), 
lysozyme (11,52,66), a complement cleavage product, C3a 
(31), thymidine (121), arginase (24), neutral proteases (1, 
2) and cationic proteins (67,101). Although cytotoxic, 
several of these agents may digest dead target cells (56) 
killed by predominantly oxidative mechanisms (15,76,118). 
6 
Particle ingestion by phagocytes is associated with 
a metabolic burst characterized by an increase in oxyge~ 
consumption, an enhanced oxidation of glucose via the 
hexose monophosphate shunt (HMP) pathway, and a substantial 
production of hydrogen peroxide (H 20 2 ) and superoxide (02) 
(48). The superoxide anion, formed by the addition of an 
electron to molecular oxygen, can gain an additional elec-
tron to produce H20 2 or lose an electron to produce molec-
ular oxygen (4). Two superoxide radicals can be spontan-
eously dismutated to H20 2 and oxygen or enzymatically 
converted to these products by the action of superoxide 
dismutase (SOD) (79): 
02 + 02 + 2H+ ~ H202 + 02 
The resulting H2o2 can also be removed enzymatically to 
produce H20 and oxygen by the action of catalase. 
The toxicity of 02 and H20 2 for microorganisms 
was initially proposed by McCord et al (80), since aerobic 
organisms contain relatively high levels of SOD and cata-
lase while strict anaerobes lacked these enzymes. The main 
function of these enzymes was hypothesized to protect 
microorganisms normally exposed to oxygen from reactive 
oxygen metabolites. This theory was supported by the 
finding that not only was superoxide anion capable of 
killing organisms, but exposure of ~coli to high oxygen 
tensions induced an increase in microbial SOD levels (38). 
However, it is not clear that microbial SOD or catalase 
can protect microorganisms from damage by external oxyg_en 
metabolites (61,118). While C. albicans contained ten 
times the concentration of SOD and catalase as ~ parap-
silosis, both species were killed equally by chemically-
generated oxygen radicals (118). Also, Lehrer found that 
c. albicans was killed more easily by reagent H2o2 than 
was~ parapsilosis at all concentrations tested (61). 
7 
On the other hand, SOD and catalase may be protective 
during the interaction of organisms with phagocytic cells. 
Neutrophils were reported to kill a low-catalase strain 
of~ aureus more easily than a high-catalase strain (77); 
catalase-deficient macrophages, whether the deficiency was 
genetic or chemically-induced, were better able to kill 
Toxoplasma gondii (88). 
The production of H202 and 02 by phagocytes may 
also lead to the formation of other reactive oxygen species 
(4) possessing antimicrobial activity (118). Such agents 
include hydroxyl radical (·OH) and singlet oxygen ( 10 2), 
which may be produced as a result of the interaction of 
02 and H202 in the following manner: 
02 + H20 2 + 10 2 + OH- + •OH 
The observed microbicidal activity of phagocyte-produced 
H2o2 and 02 may therefore result from the formation of 
other highly reactive oxygen metabolites, as well (56). 
8 
Of the mononuclear phagocytes of various origin 
and physiological state assessed for candida! killing 
capacity, resident rabbit alveolar macrophages have been 
reported to be candidastatic (103) or candidacidal (65), 
while human blood monocytes (62,69) have been shown to be 
effectively candidacidal. Resident mouse (118) or rabbit 
(65) peritoneal macrophages have been demonstrated to be 
less candidacidal than resident rabbit alveolar macrophages. 
Stanley and Hurley reported that resident mouse peritoneal 
macrophages could ingest Candida yeast cells, but these 
macrophages were eventually destroyed by the intracellular 
elongation of hyphal elements (122). Others have demon-
strated that casein-elicited mouse peritoneal macrophages 
suppress the metabolism and growth of phagocytosed yeast 
cells for 2-3 hours, but thereafter candida! growth pro-
ceeds, resulting in the destruction of the macrophage (99). 
In these instances, however, mouse peritoneal macrophages 
were maintained in culture for 24-48 hours before infection 
which may have resulted in a reduced fungicidal (59) capac-
ity for these cells similar to that observed for other 
cultured mononuclear phagocytes. 
The ability of resident macrophage populations to 
increase their fungicidal efficacy as a result of stimu-
lation is also relevant. Sasada and Johnston (118) have 
reported that LPS-elicited or BeG-activated mouse peritoneal 
9 
macrophages killed 2-3 times more c. albicans cells than 
did resident macrophages during a 2-3 hour period. In the 
host, resident macrophages may develop an enhanced capacity 
to kill Candida cells via interaction with other cells or 
factors (82,85). For example, the required presence of 
lymphocytes for the development of activated macrophages 
and the subsequent development of normal cell-mediated 
immunity against such intracellular pathogens as Listeria 
or Mycobacterium has been demonstrated by Mackaness and 
others (72,98). The lymphokine responsible for the priming 
of macrophages for an enhanced oxidative and antimicrobial 
response to Toxoplasma gondii has recently been identified 
as interferon-y (94). Maiti ~ al (73) demonstrated that 
mouse peritoneal macrophages activated in vivo by BCG or 
in vitro by exposure to phytohemagglutinin-induced lympho-
kines exhibited greater phagocytic and candidacidal activ-
ity than resident peritoneal macrophages. The highest 
phagocytic and candidacidal activity, however, was produced 
by exposure of macrophages to Candida-induced lymphokines. 
Immune mouse serum also enhanced the phagocytic and candi-
dacidal activity of resident, but not activated, macro-
phages. Therefore, humoral and cell-mediated mechanisms 
may be required for an effective macrophage-mediated con-
trol of candida! infection in the host. 
10 
Immunomodulatory agents such as LPS or MDP appar-
ently act via a lymphokine-independent mechanism of ma~ro­
phage stimulation (48). These agents can directly prime 
cultured mouse macrophages for an enhanced oxidative re-
sponse (49) in the absence of lymphocytes or lymphokines 
(100). Evidence to support the lymphokine independence of 
this mechanism includes: 1) the rapid (16 hour) response 
of cultured macrophages to MDP and LPS; 2) the normal 
response of macrophages from nude mice lacking mature T 
lymphocytes; 3) the defective response of abnormal macro-
phages not correctable by the addition of normal lympho-
cytes; and 4) the responsi~eness of the macrophage-like 
cell line J774.1 to LPS and MDP (100). MDP has been re-
ported by others to enhance lymphocyte functions (14,123) 
as well, but the immediate target cell responsible for 
these effects was determined to be the macrophage (32). 
Others have also reported that lymphocytes are not required 
for LPS induction of tumor cell lysis (28) facilitated by 
an enhancement of macrophage oxidative responses (92). 
In vivo priming for an enhanced oxidative response 
by cultured macrophages has also been achieved by sub-
cutaneous injection of mice with MDP (23). Similar results 
were obtained with nude mice, indicating that in vivo 
priming can be accomplished in the absence of mature T 
cells. However, in the immunologically normal animal, 
11 
activation by this agent might result from a combination 
of lymphokine release and a direct effect on the macrophage. 
The enhanced oxidative response induced by the 
elicitation or activation of macrophages by LPS, BCG, or 
MOP in vivo directly correlates to the augmentation of 
candida! killing by macrophages in vitro (23,118). In 
addition, administration of MOP prior to or immediately 
following infection with ~ albicans prolongs the survival 
of intravenously inoculated mice (23). 
The reactive oxygen metabolites hydrogen peroxide 
CH202), superoxide (02), hydroxyl radical (•OH) and singlet 
oxygen ( 102) have all been; implicated in macrophage can-
didacidal activity (118). Candida parapsilosis, a less 
pathogenic species of fungi, elicited a greater oxidative 
response and was killed more efficiently by mouse peri-
toneal macrophages than was~ albicans (118). Killing of 
both candida! species was inhibited by the exogenous addi-
tion of enzymes which remove H202 (catalase) or 02 (super-
oxide dismutase; SOD) or scavenge ·OH (benzoate) or singlet 
oxygen (azide) (118). Other data to support the require-
ment of oxygen metabolites in macrophage-mediated candida-
cidal activity include: 1) the macrophage-like cell line 
J774.1 produced less than 10% as much 02 as did resident 
mouse peritoneal macrophages and, although candida! in-
gestion was hormal, candida! killing did not occur (118) 
and 2) the greater candidacidal activity of LPS-elicited 
and BeG-activated macrophages relative to resident mouse 
peritoneal macrophages was associated with an enhanced 
capacity to release 02 upon exposure to .a membrane-per-
turbing agent, phorbol myristate acetate (PMA), or phago-
cytic particles such as opsonized zymosan (49) or Candida 
(118). In addition, reagent H20 2 has been demonstrated 
to be effectively candidacidal (118). The concentration 
12 
of reagent H202 required for candidacidal activity was 
higher than that normally produced by resident or activated 
macrophages (92,118). However, the hydrogen peroxide-
producing capacity of macrophages was measured in the 
extracellular environment, where culture medium diluted 
its absolute concentration (92,96). It has been hypo-
thesized that, within the phagocytic vacuole or within 
the enclosed interstices which arise as a consequence of 
macrophage-to-target cell contact (93) , hydrogen peroxide 
levels can reach effectively cytocidal concentrations. 
Cytochemical techniques have documented that secretion of 
02 and H2o2 during phagocytosis is greatest at the region 
of cell surface contact (10). 
An alternative explanation·suggests that macrophage-
produced H2o2 is cytocidal because it is generated at a 
low concentration over a prolonged period of time and that 
this continued oxidative insult results in target cell 
13 
destruction (97). To support this hypothesis, Nathan et al 
(97) covalently coupled glucose oxidase to starch particles 
to facilitate contact between tumor cells in culture and 
the enzyme system. In the presence of glucose, this system 
generated H20 2 at a level equivalent to macrophages and 
was 100% tumoricidal. Evidence supporting the candidacidal 
effectiveness of a sustained production of oxygen metabo-
lites arises from experiments in which a cell-free acet-
aldehyde-xanthine oxidase 02- and H2o2-generating system 
killed Candida and where candida! killing was inhibited 
by the exogenous addition of SOD or catalase (118). 
Oxygen-dependent mechanisms are important to the 
candidacidal activity of the polymorphonuclear leukocyte 
(PMN) (60,63) and monocyte (62), as well as to the macro-
phage, since patients suffering from chronic granulomatous 
disease (CGD), a disease in which patients' phagocytes 
ingest organisms normally, but are deficient in 02 and 
H2o2 production (27,46), have an impaired ability to kill 
Candida. However, the oxygen-dependent mechanisms utilized 
by the PMN and monocyte may differ from that of the macro-
phage, since, unlike the macrophage, H202-mediated killing 
by these cells is enhanced by a myeloperoxidase-H 20 2 -
halide system (56). Although peroxidase activity has been 
demonstrated histochemically (6) and biochemically (109) 
in macrophages, as circulating blood monocytes mature into 
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resident tissue macrophages there is a progressive loss in 
peroxidase activity (89). Although peroxidase activity· in 
guinea pig peritoneal macrophages is located in the peri-
nuclear cisternae, the Golgi vesicles and in some membrane-
bound granules (22,25), the functional relevance of this 
enzymatic activity in relation to H2o2-mediated killing 
mechanisms remains to be established. 
The enzyme primarily responsible for the respira~ 
tory burst in guinea pig macrophages has recently been 
identified as a membrane-bound oxidase that preferentially 
uses NADPH as substrate (8). Evidence supporting a mem-
brane-bound NAD(P)H oxidase as the principle respiratory 
burst enzyme includes: 1) the 100,000 x g supernatants 
prepared from homogenates of both resting (resident) and 
PMA-stimulated macrophages oxidized very low levels of NADH 
and NADPH with the subsequent formation of 02; 2) the 
100,000 x g pellet prepared from homogenates of resting 
cells also oxidized NADH and NADPH with subsequent 02 
formation, but activity in homogenates from PMA-stimulated 
macrophages was substantially increased and higher with 
NADPH than with NADH as substrate; 3) the Km for NADPH was 
one-tenth that for NADH, and the maximum velocity of 02 
production was twice as great with NADPH as with NADH; 4) 
unlike myeloperoxidase (MPO), the oxidase was insensitive 
tti azide and cyanide; 5) a direct correlation existed 
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between the degree of intact macrophage respiratory activ-
ity and the activity of the oxidase (8). 
Of further interest, pre-incubation of oil-elicited 
macrophages with immunomodulatory agents such as LPS and 
MDP has been reported to result in an enhanced production 
of 02 via the activation of the NAD(P)H oxidase of macro-
phages (51) • NADPH-dependent 02 production was enhanced in 
macrophages pre-treated with LPS or MDP for as little as 
15 minutes prior to stimulation with cytochalasin E or 
wheat germ agglutinin as compared to macrophages which had 
not received LPS or MDP (51). Given this information and 
given that macrophage cand~dacidal activity has been di-
rectly correlated to the ability of stimulated macrophages 
to produce reactive oxygen metabolites such as H202 and 02 
(118), the potential enhancement of macrophage candida! 
killing by SM-1213, via the stimulation of macrophage 
NAD(P)H oxidase and the subsequent production of H20 2 and 
02, was examined and is described in the following report. 
CHAPTER II 
MATERIALS AND METHODS 
A. Experimental Drugs 
SM-1213 [1,2-0-isopropylidene-3-0-3'-(N',N'-di-
methylamino-n-propyl)-D-glucofuranose, monohydrochloride] 
was obtained from Greenwich Pharmaceuticals, Inc., Green-
wich, CT. Muramyl dipeptide (MDP, N-acetyl-muramyl-L-
alanyl-D-isoglutamine·~ H20, grade A; Calbiochem-Behring 
Corp. La Jolla, CA) was used in some experiments in par-
allel with SM-1213, since both agents are substituted sugar 
moieties with immunomodulatory properties (13,35). The 
chemical structures of SM-1213 and MDP are presented in 
Figure 1. Drug solutions were endotoxin-free as determined 
by the Limulus amebocyte lysate assay (Sigma Chemical Co., 
St. Louis, MO). 
B. Fungal Strain 
Candida albicans, serotype A [a clinical isolate 
demonstrating typical carbohydrate assimilation, hyphal 
formation in serum and chlamydospore formation on cornmeal-
tween agar (Uni-Yeast Tek system; Corning Medical Micro-
biology, Roslyn, NY)], was grown aerobically on Sabouraud's 
dextrose agar (SDA; Difco, Detroit, MI) for 24 h at 37°C 
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Figure 1. A. The chemical structure of SM-1213 [1,2-0-
isopropylidene-3-0-3'-(N',N'-dimethylamino-
n-propyl)-D-glucofuranose, monohydrochloride] 
B. The chemical structure of muramyl dipeptide 
(MDP; N-acetyl-muramyl-L-alanyl-D-isoglutamine) 
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prior to use. Under these conditions, greater than 98% of 
the Candida cells were in the yeast phase. 
c. Growth of Candida albicans 
When Candida which had been grown on SDA were 
inoculated into Sabouraud's dextrose broth (SDB; Difco), 
greater than 98% of Candida grew as yeast. Therefore, to 
determine whether SM-1213 had a direct growth inhibitory 
effect on the yeast form of Candida, 500 ml side-arm Erlen-
meyer flasks containing 100 ml of SDB were inoculated with 
1 X 10 5 cfu. Flasks were incubated aerobically at 37oc on 
a rotary shaker. The increase in absorbance in flasks 
with the following concentrations of SM-1213 was monitored 
hourly over a period of 10 h: 0 (control), 1, 10, 100 and 
1000 ng/ml. Absorbance readings were taken at 660 nm on a 
Spectronic 70 spectrophotometer (Bausch and Lomb, North-
brook, IL). 
When Candida which had been grown on SDA were 
inoculated into serum-free Waymouth's medium (Flow Labora-
tories, McLean, VA) supplemented with 2 mg/ml bovine serum 
albumin (fraction IV, essentially fatty acid free; Sigma), 
5 ~g/ml oleic acid (Sigma) and 50 ~g/ml gentamicin (Scher-
ing Pharmaceutical Corp., PR), greater than 98% of Candida 
developed hyphae after 6 h of incubation at 37°C. Candida 
cells displaying elongated germ tubes or pseudohyphae were 
defined as "hyphal" in form. To determine whether SM-1213 
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had a direct growth inhibitory effect upon the hyphal form 
of Candida, 2SO ml flasks containing SO ml of supplemented 
waymouth's medium (SWA medium) with the above concentra-
tions of SM-1213 were inoculated with 1 X 10s cfu and 
incubated aerobically for 24 h on a rotary shaker at 37oc. 
Since mycelial mass formation prohibited growth analysis 
by absorbance measurements, hyphal growth was determined 
in each flask by dry weight analysis after Millipore fil-
tration of the cultures. Three washes of the Candida were 
performed with distilled water during each filtration 
(0.4S ~m pore size), followed by oven drying of the filters 
at 60°C for 48 h. 
D. Leukocyte Harvest 
One male guinea pig (Hartley strain, 7SO g) was 
used in each of the experiments as a source of peritoneal 
exudate cells (PEC). To obtain oil-elicited peritoneal 
exudate cells (PEC-0), 20 ml of paraffin oil (light, white 
mineral oil; Fisher Scientific Co., Chicago, IL) was in-
jected into the peritoneal cavity 72 h prior to animal 
sacrifice. PEC-0 were harvested from the peritoneum by 
five serial washes of 20 ml volumes of ice-cold Eagle's 
basal medium (Flow) containing SO ~g gentamicin/ml (Scher-
ing) and S units sodium heparin/ml (Upjohn, Kalamazoo, MI). 
The washes were delivered into sterile polystyrene tubes 
and the cells were pelleted by centrifugation at 2SO x g 
for 5 min at 2ooc in an International PR-6 centrifuge 
(International Equipment Co., Needham Heights, MA). The 
cells were washed by centrifugation in phosphate buffered 
saline (PBS, pH 7.3, % w/v in distilled water: NaCl 0.8, 
KCl 0.02, KH2P04 0.012 and Na 2HP0 4 0.091), quantified in 
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a hemacytometer, and diluted to the appropriate concen-
tration in SWA medium. Differential counts of at least 
200 PEC-0 were performed on Wright-Giemsa stained smears. 
The average cellular profile derived from multiple experi-
ments was as follows: 77.2 ± 0.8% macrophages and mono-
cytes, 2.6% PMN and 20.2% lymphocytes, mast cells and 
eosinophils. Total cellular harvest per animal averaged 
1.17 (±0.14) X 108 PEC-0. 
To obtain resident peritoneal exudate cells (PEC-r), 
harvesting procedures were identical to those described 
above; however, no oil or other inducing agent was used. 
The average cellular profile for resident PEC was as fol-
lows: 93.0 ± 3.3% macrophages and monocytes, 0% PMN and 
7.0% lymphocytes, mast cells and eosinophils. Total cellu-
lar harvest per animal averaged 3.07 (±0.61) X 10 7 PEC-r. 
After 2 h in culture, greater than 95% of resident or oil-
elicited adherent cells consisted of macrophages, as deter-
mined by Wright-Giemsa stain. 
E. Cell Culture 
PEC (>97% viable by trypan blue dye exclusion) 
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were seeded onto 60 mm diameter plastic petri plates (tis-
sue culture grade; Becton Dickinson Co., Oxnard, CA) t~ a 
final concentration of 2 to 5 X 106 cells per plate in a 
total incubation volume of 3 rnl. In some studies, 16 mm 
diameter wells (24-well, rnultiwell tissue culture plates; 
Becton Dickinson) were plated with 1 to 2.5 X 106 PEC per 
well in a total incubation volume of 2 rnl. To allow attach-
ment of PEC to the plates, cells were incubated in SWA 
medium with or without SM-1213 for 2 h at 37°c in 95% air-
S% C02. After 2 h, non-adherent cells were removed by 
washing once with SWA medium and appropriate medium (with 
or without SM-1213) was replaced for those samples requir-
ing further incubation. Final concentrations of SM-1213 
in the incubation medium were: 0 (control), 0.1, 1, 10, 
and 100 ng/rnl. 
In experiments examining Candida-infected PEC, 
cell culture procedures were as described above except 
that yeast cell suspensions were inoculated into the cul-
ture medium directly following the addition of peritoneal 
cells in a Candida-to-PEe ratio of 1:5 to 1:10. 
F. Candida! Hyphal Elongation 
PEC were delivered into plastic petri plates (60 
mrn) containing two 2.2 ern square glass cover slips and were 
inoculated with Candida yeast cells as described above. At 
intervals of 2, 4 or 6 h, a cover slip with adherent, 
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infected PEC was removed from each of duplicate culture 
dishes, fixed in 95% methanol for 5 min, and inverted onto 
a microscope slide. The infected peritoneal cells were 
examined by phase contrast microscopy at lOOOX for intra-
cellular hyphal formation and elongation, since viable 
yeast cells converted to the hyphal form intracellularly. 
The hyphal lengths of Candida contained in 50 to 200 peri-
toneal cells were determined by a microscope eyepiece 
micrometer. 
G. Candida! Viability 
Hyphal viability was quantitatively determined by 
the microcolony method (45~. This method took advantage 
of the dimorphic nature of c. albicans, which grew exclu-
sively (>98%) in the yeast form when incubated aerobically 
on SDA. Briefly, a cover slip was removed from each of 
duplicate culture dishes and rinsed in successive baths of 
PBS and SOB. Washed cover slips were drained by touching 
the cover slip to filter paper. The cover slips were in-
verted onto SDA (3 mm thick) and incubated aerobically at 
30°C. Similar results were obtained if PEC were first 
lysed with a solution of 0.5% Non-idet detergent (Sigma) 
before placement of the cover slips on agar. The cultures 
were examined by phase contrast microscopy for Candida 
microcolony formation. Each Candida which produced at 
least one microcolony of four adjacent yeast cells was 
defined as viable. The percentage of non-viable Candida 
was determined by counting 100 to 200 Candida-containing 
peritoneal cells: 
% 
Candida = 
killed 
Number of Candida unable 
to form m1crocolonies ~N:-u-rnb-;--e-r-o~frc=-a.;;..n.;;..d~1~d;;;;a;.;;;.;::...;;..:;N:-;urnb~:;.;e;.;.r;;;..;;;;.o~f~C:-a-n"""dM1,...,d=--a X 10 0 
able to form + unable to form 
microcolonies microcolonies 
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Additional experiments were conducted to determine 
the effect of SM-1213 pre-treatment of PEC on their capacity 
to inhibit intracellular hyphal elongation and to reduce 
candidal viability subsequent to the removal of the drug. 
PEC were pre-incubated with drug for 2, 4, or 6 h and washed 
3X in SWA medium to removeiresidual drug prior to inocula-
tion with yeast cells. Hyphal elongation was determined 
microscopically by eyepiece micrometer and candidal via-
bility was assessed by the microcolony technique previously 
described 2 h after infection of PEC. 
In some experiments, both the microcolony technique 
and the methylene blue dye exclusion technique of Lehrer 
and Cline (63) were used for determining candidal viability. 
H. Enzyme Assays and Protein Determination 
Culture fluid and non-adherent cells were removed 
from culture dishes at 2 h and again at 4 or 6 h for sam-
ples incubated for 4 or 6 h, respectively. Values obtained 
at 2 h were combined with those obtained at 4 or 6 h to 
represent total non-adherent PEC or culture fluid values 
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over the 4 or 6 h incubation period. 
Non-adherent PEC and extracellular Candida, if 
present, were separated from the culture fluid by centrifu-
gation at 500 X g, 4°C for 10 min. The pellet was treated 
with 3 ml 1% Triton X-100 detergent (TX-100; Sigma) for 10 
min to disrupt non-adherent PEC or, in Candida-infected 
samples, with 0.5% Non-idet detergent (NI; Sigma). NI was 
used on infected samples since, at this concentration 
(0.5%), it disrupted PEC without affecting the viability 
of Candida cells. Following disruption of non-adherent 
PEC, cellular debris and Candida cells, if present, were 
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removed by centrifugation at 1000 x g, 4 C for 10 min. 
c 
At 2, 4, or 6 h, ddherent PEC were treated with 
3 ml of 1% TX-100 or 0.5% NI for 10 min to disrupt the 
attached cells. A rubber policeman was used to facilitate 
the removal of cells from culture dishes. Cellular debris 
and Candida cells, if present, were pelleted by centrifu-
o gation at 1000 x g, 4 C for 10 min. 
Culture fluid and supernatants from adherent and 
non-adherent cell lysates were either stored frozen at 
-40°C until assayed or, since freezing and thawing resulted 
in a decrease in catalase activity, samples to be assayed 
for this enzyme were assessed immediately after centrifuga-
tion. Enzyme activities for adherent and non-adherent PEC 
fractions were expressed in units per mg adherent cell or 
non-adherent cell protein, respectively. Enzyme activities 
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for culture fluid fractions were expressed in units per mg 
total cell protein. Enzyme assays and protein determina-
tions were performed as follows: 
1. Catalase (EC 1.11.1.6) 
Catalase activity was determined by the method of 
Beers and Sizer (7) in which the disappearance of reagent 
hydrogen peroxide (Mallinckrodt, Inc., Paris, KY) was 
followed spectrophotometrically at 240 nm. The decrease 
in absorbance was measured with a Gilford 2400 recording 
spectrophotometer for a period of 3 min at 25°c. Each 
cuvette contained 1.9 ml glass distilled H2 0 and 1.0 ml 
0.059 M H2 0 2 in 0.05 M KH 2 Po4 buffer (pH 7.0) to which 0.1 
ml of the biological sample was added. Catalase activity 
in units was calculated using bovine liver catalase (thymol 
free, 17,000 U/mg protein; Sigma) as standard. One unit 
decomposed 1 pmole H2o2 per min at 25oc, pH 7.0, as deter-
mined from absorbance measurements at 240 nm using a molar 
extinction coefficient of 70 M- 1cm- 1 for H2o2 (7). 
2. Peroxidase (EC 1.11.1.7) 
Peroxidase activity was measured as the decrease 
in sample fluorescence following the oxidation of scopo-
letin (7-hydroxy-6-methoxy coumarin; Sigma) by peroxidase 
and H2o2 (114). Fluorescence was monitored for a period 
of 5 min on an Aminco-Bowman spectrophotofluorometer (Amer-
ican Instrument Co., Silver Springs, MD) with an excitation 
27 
wavelength of 350 nm and an emission wavelength of 460 nm. 
Each cuvette contained 2.2 ml 0.05 M KH 2P0 4 buffer (pH ·7.0), 
0.1 ml 0.1 M H202 and 0.1 ml 0.2 mM scopoletin in phosphate 
buffer, to which 0.1 ml of the biological sample was added. 
Peroxidase activity was quantitated from a standard curve 
using horseradish peroxidase (HPO, type I, salt free powder, 
105 U/mg solid; Sigma) as standard. One unit of HPO oxi-
dized 1 ~mole of o-dianisidine per min at 25°c, pH 5.0, as 
determined from absorbance measurements at 460 nm using a 
molar extinction coefficient of 1.13 X 10 4 M-lcm-1 (20). 
3. S-N-acetylglucosaminidase (EC 3.2.1.30) 
The method of Woollen ~ al (129) was used to 
measure S-N-acetylglucosaminidase (NAGA) activity in bio-
logical samples. The formation of p-nitrophenol from p-
nitrophenyl-N-acetyl-S-D-glucosaminide (Sigma) was deter-
mined spectrophotometrically at 400 nm. Borosilicate glass 
test tubes (16 X 125 mm), on ice, received 0.5 ml 0.1 M 
sodium citrate buffer (pH 5.0), 0.1 ml 3 mM p-nitrophenyl-
N-acetyl-S-D-glucosaminide in citrate buffer, and 0.5 ml of 
the biological sample and were incubated for 2 h at 37°C in 
a shaking water bath. Following incubation, the tubes were 
placed on ice, the reaction was stopped by the addition of 
3.0 ml 0.2 M sodium borate buffer (pH 9.8) to each tube, 
and the absorbance at 400 nm was read. Enzyme activity was 
quantified in units using jack bean NAGA (Sigma) as stand-
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ard. One unit hydrolyzed 1.0 ~mole of p-nitrophenyl-N-
acetyl-S-D-glucosarninide to p-nitrophenol and N-acetyl~ 
glucosamine per min at 25oc, pH 8.0, as determined from 
absorbance measurements at 400 nm using a molar extinction 
coefficient of 1.67 X 104 M-lcm-1 (41). 
4. Lactate dehydrogenase (EC 1.1.1.27) 
Lactate dehydrogenase (LDH) activity was determined 
by the method of Wacker ~ al (125) utilizing the principle 
that LDH catalyzes the conversion of L-lactate to pyruvate 
with the simultaneous reduction of a molar equivalent of 
nicotinamide adenine dinucleotide (NAD); the production of 
reduced NAD (NADH) , then, ~s measured by the increase in 
absorbance at 340 nm, is proportional to the activity of 
LDH. Therefore, 3 ml of the following reaction mixture 
(Super Stat Pack; Calbiochem, La Jolla, CA) were delivered 
into each cuvette, followed by 0.1 ml of biological sample: 
3.5 mM NAD, 0.05 M glycine buffer (pH 8.8), and 70 rnM lac-
tate. All components were pre-warmed in a water bath to 
the assay temperature of 3ooc. LDH activity in units was 
calculated using rabbit muscle LDH (substantially free of 
pyruvate kinase, 900 U/mg protein; Sigma) as standard. One 
unit oxidized 1.0 ~mole of lactate to pyruvate per min at 
30°C, pH 8.8, as determined from absorbance measurements at 
340 nm using a molar extinction coefficient of 6.22 X 10 3 
M- 1 cm- 1 (131). 
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5. Protein Determination 
Protein determinations on cell lysate supernatants 
were conducted according to the method of Lowry ~ al (71) 
using bovine serum albumin (fraction IV, essentially fatty 
acid free; Sigma) as standard. Working reagents were pre-
pared as follows: Reagent A consisted of 1.0 ml 2% w/v 
potassium-sodium tartrate in H20, 1.0 ml 1% w/v copper 
sulfate in H20, and 98.0 ml 2% w/v sodium carbonate in 
0.1 N NaOH; Reagent B consisted of 2 N Folin-Ciocalteu 
Phenol Reagent (Sigma) diluted 1:1 v/v with H20. Bio-
logical sample (0.1 ml) was diluted with 0.4 ml H20 and 
allowed to react for 10 min at 25°C with 2.5 ml of Reagent 
A. Reagent B (0.25 ml) was added and allowed to react for 
30 min at 25°C. Test tubes containing the reaction mixture 
were centrifuged for 5 min at 1000 x g and the absorbance 
of the supernatant at 750 nm was determined. 
I. Determination of Hydrogen Peroxide and Superoxide Anion 
Generation 
Hydrogen peroxide generation was quantitated by the 
method of Pick and Keisari (104) based on the H202-mediated, 
HPO-dependent oxidation of phenol red. Oxidized phenol red 
was measured by its absorbance at 610 nm. PEC were plated 
onto 16 mm culture dishes and incubated for 2 or 6 h in SWA 
medium to which SM-1213 or MDP was added. Dishes were 
washed once with SWA medium at 2 h to remove non-adherent 
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cells. After incubation, adherent cells were washed 3X 
with phenol red-free Earle's balanced salt solution (EBSS; 
Flow) and covered with 2 ml per dish of pre-warmed phenol 
red solution (PRS). PRS was prepared immediately prior to 
use by dissolving 0.1 mg phenol red/ml (phenolsulfonphtha-
lein, sodium salt; Sigma) and 8.5 U HPO/ml (type I, 105 
units/mg solid; Sigma) in EBSS. Opsonized zymosan was 
added to a final concentration of 1 mg/ml and the dishes 
were incubated at 37°C. Plates which did not receive op-
sonized zymosan were assessed for phenol red oxidation and 
values were subtracted from those of test samples as back-
ground oxidation. After 30 min, the culture fluid was 
transferred to tubes which were centrifuged for 5 min at 
1000 x g. Supernatants were made alkaline by the addition 
of 10 ~1 of 1 N NaOH per tube and the extracellular genera-
tion of H20 2 was determined by the absorbance at 610 nm. 
PEC adherent to the culture dishes were disrupted with 0.5 
ml 1% TX-100, scraped with a pipette tip to dislodge cells, 
and incubated for 30 min at 37°C with 2 ml PRS. The H20 2 
generation by the cell lysate was determined spectrophoto-
metrically after centrifugation and alkalinization of the 
supernatants as described above. Hydrogen peroxide con-
centration was determined using a standard curve which 
utilized PRS and a range of H202 concentrations up to 
200 ~M. 
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Superoxide anion generation was measured by one of 
two methods. Whole cell 02 generation was determined by a 
modification of the quantitative nitroblue tetrazolium salt 
(NBT) reduction test described by Weiss~ al (126). The 
major modification involved using oil-elicited guinea pig 
PEC adherent to culture dishes rather than human peripheral 
blood monocytes and neutrophils in suspension. After incu-
bation for 2 or 6 h in SWA medium to which SM-1213 was 
added, adherent cells in 60 mm dishes were washed 3X with 
PBS and covered with the NBT reaction mixture. The reac-
tion mixture contained 0.4 ml Hank's balanced salt solution 
without phenol red (HBSS; Flow), 0.4 ml 0.2% NBT in 0.85% 
saline, 0.1 ml 0.01 M KCN, and 0.1 ml opsonized zymosan or 
Candida. NBT reduction was allowed to proceed at 37°C, 
95% air-5% C0 2 atm for 15 min after which time the reaction 
was stopped by the addition of 10 ml of cold 0.5 N HCl. 
PEC were harvested from the plates with a rubber policeman, 
the suspension was centrifuged in test tubes at 1000 x g 
for 20 min, and the reduced dye was extracted from the 
pellet with 4 ml pyridine in a boiling water bath. The 
centrifugation was repeated and the supernatant absorbance 
was read at 515 nm. In some studies, cell-associated and 
extracellular NBT reduction were determined separately on 
the cell pellet and supernatant fractions, respectively. 
The concentration of NBT reduced was calculated 
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from a standard curve constructed by reducing known quan-
tities of NBT with a xanthine-xanthine oxidase system •. 
This system reduced 11.4 nmoles NBT per min at 37°C, pH 
7.0, as calculated from absorbance measurements at 515 nm 
using a molar extinction coefficient of 2.8 X 103 M-1cm-1 
(126) for NBT and contained 0.4 ml of varying concentra-
tions of NBT in 0.85% saline, 1.8 ml of 2.22 X 10-4M xan-
thine (Calbiochem), and 1.8 ml of 2.22 X lo-aM xanthine 
oxidase (grade III, from buttermilk, 1.3 U/mg protein; 
Sigma) in 0.05 KH 2Po4 buffer (pH 7.0) containing 1 X 10- 4M 
EDTA (Sigma). Xanthine oxidase (EC 1.2.3.2) concentration 
was quantitated from absorbance measurements at 450 nm 
using a molar extinction coefficient of 7 X 104 M-1cm-1 
( 78) • 
In some experiments, whole cell 02 generation was 
measured spectrophotometrically by the reduction of terri-
cytochrome c (49). After incubation for 2 or 6 h in SWA 
medium to which SM-1213 was added, adherent cells in 60 mm 
culture dishes were washed 3X with PBS and covered with 
3 ml of an 80 ~M solution of ferricytochrome c (FCC; type 
III; Sigma) in phenol red-free HBSS. Opsonized zymosan 
was added to the culture dishes which were incubated for 
90 min at 37°C in 95% air-5% C02 • After incubation, cul-
ture fluid was transferred to tubes on ice, centrifuged 
for 5 min at 1000 x g, and the absorbance of the super-
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natants at SSO nm was read. The concentration of ferri-
cytochrome c reduced was calculated using the molar extinc-
tion coefficient of 2.1 X 104 M-lcm-1 (49). 
Ferricytochrome c or NBT reduction was used to 
quantitate NADPH-dependent (SO,Sl) superoxide anion gener-
ation by cell-free PEC lysates. PEC were incubated in 16 
mm dishes for 2, 4 or 6 h either in SWA medium containing 
SM-1213 or in SWA medium alone. After incubation, adherent 
cells were washed 3X with PBS and covered with the stimu-
lant mixture: 1.6 ml phenol red-free HBSS, 0.2 ml 0.01 M 
KCN, and 0.2 ml opsonized zymosan. Samples were incubated 
at 37oc in 9S% air-S% co2 to allow phagocytosis of zymosan 
particles. After lS min, adherent cells were washed once 
with PBS, lysed by exposure to O.S ml 1% TX-100 for 10 min, 
and dislodged from the plates by scraping with a pipette 
tip. Cell lysates were incubated with the following reac-
tion mixture for lS min at 37°C in 9S% air-S% C02 : l.S ml 
phenol red-free HBSS, 0.2 ml 0.01 M KCN, 0.1 ml 0.2 M 
NADPH (Sigma), and 0.2 ml 0.8 mM ferricytochrome c or 0.2 
ml 0.4% NBT in HBSS. In addition, cell lysates from sam-
ples initially incubated in SWA medium alone and not pre-
viously exposed to SM-1213 received drug in the above 
reaction mixture in order to determine the possible direct 
effect of SM-1213 on NADPH-dependent superoxide generation 
by cell lysates. Ferricytochrome c or NBT reduction in 
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supernatants was measured spectrophotometrically by ab-
sorbance at 550 or 515 nm, respectively, after transfer· of 
samples to test tubes on ice and centrifugation for 5 min 
at 1000 x g. 
In order to determine the percentage of NBT or 
ferricytochrome c reduction mediated by 02, some samples 
were incubated in the presence of superoxide dismutase 
(SOD, from bovine blood, EC 1.15.1.1, 2800 U/mg protein; 
Sigma) at a final concentration of 3000 U/ml. Average SOD-
inhibitable reduction, compiled from multiple experiments, 
constituted 72.7 ± 14.4% of total detectable reduction. 
SOD which had been heated for 10 min in a boiling water 
bath or autoclaved for 15 min, catalase (bovine liver cata-
lase; Sigma) at a final concentration of 1700 U/ml, or 
bovine serum albumin (BSA; Sigma) was included in some 
samples measured for 02 or H20 2 generation, as indicated 
in the Results section. 
Opsonized zymosan or c. albicans was prepared by 
incubating 100 mg of zymosan (zymosan A from s. cerevisiae 
yeast; Sigma) or 1 X 108 Candida yeast cells with 6 ml of 
whole, normal guinea pig serum for 20 min at 37oc in a 
shaking water bath. The particles were washed by centri-
fugation in PBS for 5 min at 250 x g and resuspended to 
50 mg zymosan/ml or 1 X 10 7 Candida/mi. Culture dishes 
received a final concentration of 0.5 to 1 mg opsonized 
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zymosan/ml or 0.5 to 1 X 10 6 opsonized yeast cells/plate. 
Opsonization of particles was indicated by direct agglutin-
ation testing using rabbit anti-guinea pig immunoglobulins 
(Accurate Chemicals, Westbury, NY). 
J. Determination of the Candidacidal Activity of the 
NADPH-NAD(P)H Oxidase System 
The effect of SM-1213 on the candidacidal activity 
of a cell homogenate-derived NAD(P)H oxidase 02-generating 
system was determined. After incubation in SWA medium for 
2 or 6 h, adherent cells (2.5 X 10 6 PEC) in 16 mm culture 
dishes were washed once with PBS, covered with the follow-
,• 
ing stimulant mixture, and1 incubated at 370c in 95% air-
5% C02 : 1.6 ml phenol red-free EBSS, 0.2 ml 0.01 M KCN, 
and 0.2 ml opsonized zymosan. After 15 min, adherent cells 
were washed once with PBS, covered with 1.5 ml EBSS, and 
scraped with a pipette tip to disrupt and dislodge cells. 
Some samples received SOD at a final concentration of 
3000 U/ml. Cell homogenates were transferred to glass 
test tubes (16 X 125 mm) containing: D.l ml SM-1213, 0.2 
ml 0.01 M KCN, 0.1 ml 0.2 M NADPH, and 0.1 ml (8 X 105) 
Candida yeast cells in EBSS. Some cell homogenates were 
heated in a boiling water bath for 10 min and cooled to 
370C before addition to the above reaction mixture. After 
90 min at 37oc in a shaking water bath, samples were seri-
ally diluted and plated in duplicate by the spread plate 
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method on SDA. Candida! viability was assessed by colony 
enumeration after plates were incubated aerobically at ~7°C 
for 48 h. Alternatively, candida! viability was determined 
by methylene blue dye exclusion (63). Similar results were 
obtained if PEC were lysed with 0.5% NI rather than dis-
rupted by physical means. 
To determine the candidacidal activity of cell 
homogenates not dependent upon NAD(P)H oxidase, some sam-
ples did not receive substrate NADPH in the reaction mix-
ture. In samples receiving SOD, the candidacidal activity 
of the NADPH-NAD(P)H oxidase system was inhibited an aver-
age of 62.5 ± 2.89% over t~ree experiments. 
K. Statistical Analysis 
For candida! killing percentages, the Chi-square 
(x2) analysis or the Student's t test was used; for all 
other averages, the Student's t test was utilized. Aver-
ages were represented plus or minus (±) the standard error 
of the mean. Values were considered significant when 
p < 0.05. 
CHAPTER III 
RESULTS 
A. Direct Effect of SM-1213 on the Growth of c. albicans 
SM-1213 had no direct fungicidal or fungistatic 
activity against the yeast or hyphal form of Candida at 
any drug concentration tested over a 10 h (yeast) or 24 h 
(hyphae) incubation period (Table I) • 
B. Effect of SM-1213 on Hyphal Elongation of Phagocytosed 
c. albicans 
Since the development of hyphal elements has been 
implicated in the pathogen~sis of candida! disease (128), 
intracellular hyphal formation and elongation by phago-
cytosed yeast cells was measured. In SWA medium alone, 
100%.of Candida cells developed hyphae during the 6 h 
incubation period. All of the yeast cells phagocytosed 
by untreated PEC-0 initiated hyphal formation, while PEC-0 
incubated in the presence of SM-1213 (1 ng/ml) reduced the 
percentage of hyphae formed to 92% (P < 0.05). In addition, 
of those yeast cells which initiated hyphal formation, the 
average hyphal length attained after 6 h of incubation was 
shorter in drug-treated than in untreated (control) PEC-0 
(Figure 2). This effect was most pronounced at the 1 ng/ml 
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Table I. The effect of SM-1213 on in vitro growth of 
yeast and hypha! forms ofiC. albicans 
SM-1213 
concentration 
(ng/ml) 
0 
1 
10 
100 
1000 
Candida! growth (% of control) 
Yeast form~ 
100 
101 
101 
100 
101 
Hypha! formb 
100 
105 
105 
103 
98 
a) Yeast cell growth was monitored as the increase in 
absorbance of candida! cultures in SDB. Data shown 
are relative absorbance of control and drug-treated 
samples after 10 h of growth at 370C and are repre-
sentative of the absence of drug effect at earlier 
intervals. 
b) Hypha! growth was determined by dry weight analysis 
of candida! cultures as described in Methods section. 
38 
39 
Figure 2. Elongation of c. albicans hyphae 
within control and drug-treated PEC-0. PEC-0 were 
infected with c. albicans yeast cells in vitro and 
incubated in the presence of various concentrations 
of SM-1213 for the designated time intervals. Hyphal 
elongation of phagocytosed yeast cells was signifi-
cantly reduced by SM-1213 treatment of PEC-0 for 6 h, 
as indicated at right by an asterisk (*). Data repre-
sent means ± SEM derived from three experiments. 
Final drug concentration in incubation medium: (e), 
0 ng/ml; <+> , 0.1 ng/ml; <•> , 1. 0 ng/ml; (.&) , 10.0 
ng/ml. 
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drug level, a drug concentration at which no direct anti-
candida! effects were observed in the absence of PEC {Table 
I). No significant drug-induced differences in hyphal 
length were observed at any drug concentration tested after 
incubation for 2 or 4 h {Figure 2). 
Although hyphal formation was initiated intra-
cellularly, the majority of viable hyphae within control 
and drug-treated PEC-0 appeared to penetrate the phagocyte 
cell membrane by 6 h, growing into the extracellular medium. 
In these instances, then, inhibition of hyphal elongation 
was not solely "intracellular" although the mechanisms of 
growth inhibition may have ;·been initiated while hyphae were 
wholly within PEC. 
c. Effect of SM-1213 on the Killing of Phagocytosed c. 
albicans 
Although essentially all of the ~ albicans yeast 
cells phagocytosed by PEC-0 could initiate hyphal forma-
tion, some hyphae were eventually killed by the microbi-
cidal action of the phagocytic cells. As shown in Table 
II, after incubation with Candida for 6 h, untreated PEC-0 
{0 ng/ml) killed 22% of intracellular Candida while PEC-0 
incubated with Candida and either 0.1 or 1.0 ng SM-1213/ml 
for 6 h killed 35.5 or 46% of the intracellular fungus, 
respectively. At the 10 ng/ml drug level, SM-1213 did not 
induce PEC to kill a significantly greater percentage of 
Table II. The effect of SM-1213 on the viability of 
phagocytosed Candida albicans 
SM-1213 
concentration 
(ng/ml) 
Medium control£ 
0 
0.1 
1.0 
10.0 
% Candida killed 
PEC-0 incubated 
with druga 
2.5 ± o.5d 
22.0 ± 5.6 
35.5 ± 2.5*~ 
46.0 ± 9.6* 
25.0 ± ~.0 
PEC-0 pre-incubated 
with drugb 
2.5 ± 0.5 
16.5 ± 2.5 
36.5 ± 2.5* 
30.0 ± 1.0* 
34.0 ± 1.0* 
a) PEC-0 were infected and incubated with drug for 6 h. 
The percent intracellular Candida killed was deter-
mined by the microcolony techn~que as described in 
Methods section. 
b) Non-infected PEC-0 were pre-incubated with drug for 
6 h, washed, inoculated with Candida yeast cells and 
incubated for 2 h in the absence of drug. Percent 
intracellular Candida killed was determined as des-
cribed in a) above. 
c) Candida! viability was determined in PEC-free samples 
by the methylene blue dye exclusion technique (63). 
d) Mean ± SEM 
e) An asterisk (*) denotes P < 0.05 between untreated 
PEC (0 ng/ml) and drug-treated PEC samples. 
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intracellular Candida than controls. However, the initi-
ation of fungal injury was suggested by a reduction in 
average hyphal length observed for this group (Figure 2), 
although growth inhibition was not statistically signifi-
cant. 
D. Effect of SM-1213 Pre-incubation of PEC-0 on Hyphal 
Elongation of Phagocytosed c. albicans 
43 
The results presented thus far suggest that SM-1213 
could potentiate one or more intracellular candidacidal 
processes expressed by PEC-0. If such potentiation oc-
curred via the modulation of the PEC-0 themselves and not 
via a direct effect on Canqida cells, then pre-incubation 
of PEC-0 with SM-1213 and removal of drug prior to infec-
tion with Candida should result in enhanced candidal kill-
ing by drug-treated, relative to untreated, PEC-0. To 
test this hypothesis, PEC-0 were pre-incubated with SM-1213 
for 6 h and adherent cells were washed to remove residual 
drug. Monolayers were infected with yeast phase Candida 
cells, incubated for 2 h in the absence of drug, and as-
sessed for intracellular hyphal growth. Significant in-
hibition of intracellular hyphal elongation occurred during 
the 2 h incubation in PEC-0 pre-incubated with drug, at all 
concentrations tested, relative to PEC-0 pre-incubated in 
the absence of drug (Figure 3). No significant drug-
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Figure 3. Hyphal length of phagocytosed c. 
albicans within pre-incubated control and drug-treated 
PEC-0. PEC-0 were pre-incubated for 6 h in the pres-
ence or absence of drug. PEC-0 monolayers were washed, 
infected with yeast cells, incubated for 2 h in the 
absence of drug and assessed for intracellular hyphal 
growth. Each bar represents the mean ± SEM for 200 
intracellular hyphae. Hyphal length was significantly 
reduced in PEC-0 pre-incubated with SM-1213, as indi-
cated at right by an asterisk (*). 
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induced retardation of hypha! growth occurred when PEC-0 
were pre-incubated with drug for less than 6 h prior to· 
candida! infection (data not shown) • 
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E. Effect of SM-1213 Pre-incubation of PEC-0 on the Kill-
ing of Phagocytosed C. albicans 
PEC-0 were pre-incubated in culture for 6 h in the 
presence or absence of drug. Adherent PEC-0 were washed, 
infected with yeast cells, incubated for 2 h in the absence 
of drug, and assessed for candida! killing. PEC-0 pre-
incubated in the absence of drug killed 16.5% of intra-
cellular Candida during the subsequent 2 h infection period. 
In comparison, PEC-0 pre-incubated with 0.1 to 10 ng/ml 
SM-1213 for.6 h killed a significantly greater percentage 
of intracellular Candida (30-36.5%) than controls (0 ng/ml) 
during the 2 h infection period when drug was no longer 
present (P < 0.02, Table II). In all but the 10 ng/ml 
treatment group, pre-incubated PEC-0 killed an equal or 
somewhat lower percentage of intracellular Candida than 
did PEC-0 incubated with drug from the time of infection 
(Table II). However, killing of Candida within pre-incu-
bated PEC-0 was substantial, since Candida were exposed to 
PEC-0 for only a 2 h infection period relative to a 6 h 
infection period for PEC-0 incubated simultaneously with 
Candida and drug. 
47 
F. Effect of SM-1213 on PEC Enzyme Activities and Protein 
Content 
Since the work of Sasada and Johnston (118) and of 
Lehrer and Cline (64) emphasized the contribution made by 
active oxygen species such as H2 0 2 and 02 to candidacidal 
systems of phagocytes, an examination of killing mechanisms 
involving these agents was undertaken. It was decided to 
focus first on possible drug-mediated effects on the effi-
cacy, utilization and catabolism of H2o2 • This might 
result, for example, from a drug-induced modification of 
the activity of peroxidase, an enzyme associated with an 
H20 2-mediated microbicidal: system of phagocytes (62,64,102), 
or catalase, an enzyme associated with the abrogation of 
candidacidal activity of macrophages in culture (118). 
PEC were incubated with SM-1213 for 6 h and ad-
herent cell populations from resident (90-95% peroxidase 
positive), oil-elicited (45-50% peroxidase positive) and 
oil-elicited Candida-infected PEC were examined for enzyme 
activity (Table III). After 6 h of incubation with either 
0.1 or 1.0 ng SM-1213/ml, significant drug-induced reduc-
tions in catalase activity occurred in adherent cell popu-
lations from both oil-elicited and oil-elicited infected 
PEC. Such reductions in specific enzyme activity were not 
attributable to an increase in adherent cell protein as a 
result of drug treatment. Catalase activity in resident 
Table III. The effect of SM-1213 treatment of peritoneal exudate cells (PEC) on 
adherent cell enzyme activity 
SM-1213 Adherent cell enzyme activity (units/mg Erotein)a PEC type!?_ concentration 
(ng/ml) Catalase Peroxidase N-Acetyl-
Resident 
Oil-elicited 
Oil-elicited 
infected 
0 
1.0 
0 
0.1 
1.0 
0 
0.1 
1.0 
31.85 ± 0.69£ 
32.34 ± 0.46 
40.76 ± 2.64 
25.97 ± 0.83*~ 
27.79 ± 1. 95* 
61.97 ± 1. 35 
36.37 ± 1.95* 
51.02 ± 1.25* 
glucosaminidase 
10.23 ± 0.22 1. 86 ± 0.21 
11.00 ± 0.33 2.14 ± 0.09 
0.55 ± 0.07 1. 99 ± 0.11 
0.45 ± 0.08 1.40 ± 0.14 
0.64 ± 0.07 1.62 ± 0.08 
1. 76 ± 0.25 
N.D.~ 1.96 ± 0.14 
1. 96 ± 0.08 
a) Enzyme units and mg protein were determined on cell lysate supernatants from the 
isolated adherent cell fraction. 
b) Resident cells were obtained from guinea pigs on the day of the experiment by peri-
toneal lavage. Oil-elicited PEC were obtained by peritoneal lavage 72 h after 
elicitation of cells by i.p. injection of mineral oil. Oil-elicited PEC infected 
with yeast phase C. albicans at the time of PEC plating were designated as oil-elici-
ted infected PEC.--All samples were incubated with the designated concentrations of 
drug for 6 h. Culture fluid and non-adherent cells were removed prior to lysis and 
assay of adherent cell lysate supernatants. 
c) Data represent means ± SEM of triplicate dishes and are derived from one representa-
tive experiment for each PEC type. 
d) An asterisk (*) denotes P < 0.05 between control (0 ng/ml) and drug-treated. PEC 
samples. 
e) Not determined. 
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PEC was not affected by drug treatment (Table III). No 
significant drug-induced reductions in catalase activity 
were observed for any cell type incubated for less than 
6 h or for PEC-0 treated with >10 ng SM-1213/ml (data not 
shown). The observed drug-induced reduction in catalase 
specific activity in oil-elicited PEC types was selective, 
in that peroxidase levels were not affected, nor were 
levels of N-acetylglucosaminidase, a marker lysosomal 
enzyme (Table III). PEC lactate dehydrogenase activity 
and protein content (data not shown) were not significantly 
affected by drug treatment. 
Candida incubated for 6 h in medium alone followed 
i 
by treatment with 0.5% NI for 10 min exhibited no leakage 
of catalase into the extracellular medium. No detectable 
protein was released from Candida into the extracellular 
medium. Also, protein content was not greater in super-
natants from infected adherent cell lysates than in super-
natants from uninfected adherent cell lysates when PEC-0 
were derived from the same experimental animal. 
The drug-induced reduction of adherent cell cata-
lase activity was not associated with a corresponding 
enhancement of non-adherent cell or extracellular activity 
(Figure 4) , and thus could not be identified as represen-
ting a loss of cell adherence or of transfer of catalase 
from the intra- to the extracellular compartment. No 
so 
Figure 4. The effect of SM-1213 treatment of 
PEC-0 on adherent cell, non-adherent cell, and extra-
cellular catalase activities in vitro. PEC-0 were 
incubated with the designated-concentrations of drug 
for 6 h. Experimental conditions were as described 
in Methods section. Data represent the mean ± SEM of 
triplicate or quadruplicate dishes and were derived 
from one representative experiment. Significant drug-
induced reductions in catalase activity were observed 
for the adherent cell population only, as indicated 
at right by an asterisk (*). 
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direct drug effect on standard bovine liver catalase activ-
ity was observed when drug was added during enzyme assay. 
G. Effect of SM-1213 Pre-incubation of PEC-0 on NBT Re-
duction by Phagocytes after Ingestion of Opsonized 
c. albicans 
An explanation for the reduction of catalase ac-
tivity observed in drug-treated PEC-0 and the relationship 
of this reduction to the production of active oxygen spe-
cies responsible for candidal killing by phagocytes was 
suggested by the work of Kono and Fridovich (57). They 
demonstrated that catalase activity was reduced by the 
action of 02 on the heme pqrtion of the enzyme. Similarly, 
the author has observed a reduction in catalase activity 
during exposure of the enzyme to a xanthine-xanthine oxi-
dase superoxide generating system (unpublished observation, 
C.J. Morrison). It was therefore decided to examine the 
effect of SM-1213 treatment of phagocytes on their ability 
to generate 02 and H20 2 ~ vitro. In all studies regarding 
the production of active oxygen species by phagocytes, oil-
elicited PEC were pre-incubated ~ vitro in the presence or 
absence of drug for the indicated time intervals, washed, 
and then exposed to the assay conditions described. 
Figure 5 depicts the significantly enhanced pro-
duction of 02 by PEC-0 pre-incubated with SM-1213, as 
assessed by NBT reduction during phagocytosis of opsonized 
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Figure 5. The effect of SM-1213 pre-incuba-
tion of PEC-0 on NBT reduction by phagocytes during 
ingestion of opsonized c. albicans. PEC-0 were pre-
incubated for 2 or 6 h With the designated concentra-
tions of drug, washed, and adherent PEC-0 were exposed 
to the NBT assay system with opsonized Candida as 
phagocytic stimulus. Data represent the mean ± SEM 
of triplicate dishes and were derived from one repre-
sentative experiment. Significant drug-induced en-
hancement of SOD-inhibitable NBT reduction was ob-
served, as indicated at right by an asterisk (*). 
UNO = undetectable SOD-inhibitable NBT reduction. 
BSA or boiled SOD did not inhibit NBT reduction; 
Candida alone did not reduce NBT. 
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candida. Although 02 production was reduced at 6 h rela-
tive to 2 h, SM-1213 treatment enhanced 02 production by 
PEC-0 at both time intervals (Figure 5). The reduction in 
o; generation at 6 h was not due to a loss of PEC-0 via-
bility as assessed by trypan blue dye exclusion or due to 
a reduced phagocytic capacity. SOD equally inhibited NBT 
reduction in control and drug-treated samples and drug-
induced differences in SOD-inhibitable NBT reduction were, 
therefore, not due to a drug action on SOD itself. 
In order to more fully understand the mechanisms 
whereby PEC-0 kill Candida, it was of interest to examine 
the location of 02 product~on by PEC-0, that is, to differ-
entiate between NBT reduction occurring extracellularly 
and that associated with the cell. This was accomplished 
by transferring the NBT reaction fluid from the culture 
dishes to test tubes and by stopping the reaction separ-
ately in the tubes (extracellular) and dishes (cell-associ-
ated) after the 15 min incubation period. The majority of 
NBT reduction occurred extracellularly and accounted for 
an average of 74.4% of the total NBT reduced by all samples. 
In samples pre-incubated in the absence of drug for 6 h, 
100% of the SOD-inhibitable reduction of NBT occurred 
extracellularly. In contrast, in samples treated with 
1 ng SM-1213/ml, 66% of the SOD-inhibitable reduction of 
NBT occurred extracellularly. NBT reduction was not in-
hibited by boiled SOD or by BSA. Candida alone did not 
reduce NBT. 
H. Effect of SM-1213 Pre-incubation of PEC-0 on NBT and 
FCC Reduction by Phagocytes after Ingestion of Opson-
ized Zymosan 
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PEC-0 were pre-incubated in the presence or absence 
of SM-1213 for 2 or 6 h, washed, and exposed to the NBT 
assay system with opsonized zymosan as phagocytic stimulus. 
NBT reduction by PEC-0 pre-incubated with SM-1213 was en-
hanced relative to PEC-0 pre-incubated in the absence of 
drug, as depicted in Figure 6. This drug-induced enhance-
ment was most pronounced a~ the 1.0 ng/ml dose level. 
Opsonized zymosan (Figure 6) stimulated a greater reduction 
of NBT by PEC-0 than opsonized Candida (Figure 5) and was 
therefore used as the phagocytic stimulus in the remaining 
experiments. 
In order to confirm the observed drug-induced 
enhancement of 02 production by PEC-0, a second method 
typically used to assess 02 production by phagocytes, 
ferricytochrome c (FCC) reduction, was utilized. Results 
were expressed as nmoles FCC reduced per mg protein per 
90 min to conform to the standard reporting format. As 
Figure 7 depicts, pre-incubation of PEC-0 with SM-1213 
resulted in a significantly enhanced reduction of FCC by 
phagocytes during ingestion of opsonized zymosan. As in 
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Figure 6. The effect of SM-1213 pre-incuba-
tion of PEC-0 on NBT reduction by phagocytes during 
ingestion of opsonized zymosan particles. PEC-0 were 
pre-incubated for 2 or 6 h with the designated con-
centrations of drug, washed, and adherent PEC-0 were 
exposed to the NBT assay system with opsonized zymosan 
as phagocytic stimulus. Data represent means ± SEM 
of duplicate or triplicate dishes and were derived 
from one representative experiment. Significant drug-
induced enhancement of SOD-inhibitable NBT reduction 
was observed, as indicated at right by an asterisk (*). 
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Figure 7. The effect of SM-1213 pre-incubation of PEC-0 on ferricyto-
chrome c reduction by phagocytes during ingestion of opsonized zymosan particles. 
PEC-0 were pre-incubated for 2 or 6 h in the presence or absence of SM-1213, 
washed, and adherent PEC-0 were exposed to the FCC assay system with opsonized 
zymosan as phagocytic stimulus. Data represent means ± SEM of triplicate dishes 
and were derived from one experiment. Significant drug-induced enhancement of 
SOD-inhibitable FCC reduction was observed, as denoted below by an asterisk (*). 
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Figures 5 and 6, although Oz production was reduced at 6 h 
relative to 2 h, SM-1213 treatment enhanced 02 production 
by PEC-0 at both time intervals (Figure 7) . 
I. Effects of SM-1213 Treatment of PEC-0 or PEC-0 Lysates 
on NADPH-dependent Superoxide Generation by Cell Ly-
sates 
It is generally agreed that the enzyme primarily 
responsible for superoxide production by stimulated phago-
cytes is a cyanide-insensitive oxidase which utilizes a 
reduced pyridine nucleotide as substrate (8,16,91). NAD-
(P)H oxidase has been demonstrated to be involved in Oz 
production when phagocytes; are stimulated by membrane-
perturbing agents such as phorbol myristate acetate (8), 
or by phagocytic particles such as opsonized zymosan (91). 
In order to determine whether a drug-mediated effect on 
this enzyme was responsible for the observed enhancement 
of 02 production by PEC-0 pre-incubated with SM-1213, 
an examination of NADPH-dependent FCC and NBT reduction 
was initiated. 
PEC-0 were pre-incubated in the absence or pres-
ence of SM-1213 for various time intervals and washed 
prior to stimulation with opsonized zymosan. Following 
stimulation, PEC-0 were lysed with detergent and cell 
lysates were assayed for NADPH-dependent NBT or FCC reduc-
tion in the presence of exogenously added NADPH. 
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Figure 8 depicts the significant enhancement of 
NADPH-dependent FCC reduction by lysates from PEC-0 pre~ 
incubated with SM-1213 for 6 h. Treatment at the 1.0 ng/ml 
drug concentration enhanced NADPH-dependent FCC reduction 
after 2 h to a level which approached significance (0.1 > 
p > 0.05). 
A significant enhancement of NADPH-dependent NBT 
reduction by cell lysates was also observed (Figure 9) 
when PEC-0 were pre-incubated for 6 h with 0.1 or 1.0 ng 
SM-1213/ml prior to cell lysis. No significant drug-
induced increase in 02 production was observed when PEC-0 
were pre-incubated for les~ than 6 h (Figure 9). PEC-0 
pre-incubated in the absence of drug for 6 h and receiving 
no substrate NADPH at the time of NBT assay demonstrated 
relatively minimal NBT reduction (Figure 9). The reduced 
activity observed at 0 h may have resulted from the pres-
ence of SOD (75) from minor red blood cell contamination 
present in PEC-0 cell suspensions at this time interval 
only. 
The reduction of 02 production at 6 h relative to 
2 h observed for whole cell NBT and FCC reduction (Figures 
5, 6, 7) was not observed for 02 production by cell lysates 
(Figure 9). Instead, an increase in 02 production was 
observed at 6 h relative to earlier time intervals and only 
at 6 h was a significant drug-induced enhancement of NBT 
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Figure 8. Drug enhancement of NADPH-dependent 
FCC reduction by cell lysates from PEC-0 pre-incubated 
with SM-1213. PEC-0 were pre-incubated in the pres-
ence or absence of SM-1213 for 2 or 6 h and adherent 
PEC-0 were washed prior to stimulation with opsonized 
zymosan and cell lysis. Cell lysates were assayed for 
FCC reduction as described in Methods section. Data 
represent means ± SEM of triplicate dishes and were 
derived from one experiment. Significant drug-induced 
enhancement of SOD-inhibitable NADPH-dependent FCC 
reduction was observed, as denoted at right by an 
asterisk (*). 
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Figure 9. Time-dependent drug enhancement of NADPH-dependent NBT reduc-
tion by cell lysates from PEC-0 pre-incubated with SM-1213. PEC-0 were pre-
incubated in the presence or absence of SM-1213 for 2, 4 or 6 h and adherent 
PEC-0 were washed prior to stimulation with opsonized zymosan and cell lysis. 
Cell lysates were assayed for NBT reduction as described in Methods section. At 
0 h, PEC-0 in suspension (consisting of 77% macrophages, 3% PMN and 20% lympho-
cytes) were incubated with the opsonized zymosan stimulant mixture, washed by 
centrifugation in PBS and lysed. Lysates were assayed for NBT reduction as des-
cribed in Methods section. Cell lysates from PEC-0 pre-incubated in the absence 
of drug for 6 h and receiving no substrate NADPH at the time of NBT assay are 
designated below as NO NADPH. An as,terisk (*) denotes P < 0.05 between samples 
obtained from PEC-0 pre-incubated in the absence of drug and those from PEC-0 
pre-incubated in the presence of drug. Data represent means ± SEM of the number 
of experiments denoted in parentheses ( ). 
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reduction observed (Figure 9). 
In order to determine whether the time-dependen.t 
nature of the observed drug effect was a result of the 
time PEC-0 were exposed to SM-1213 or whether it was a 
result of the time PEC-0 were held in culture, PEC-0 were 
pre-incubated for 2 or 6 h in the absence of drug prior to 
stimulation with opsonized zymosan and cell lysis. Cell 
lysates were then assayed for NBT reduction in the pres-
ence or absence of SM-1213. 
Table IV compares NADPH-dependent NBT reduction by 
cell lysates from PEC-0 pre-incubated with SM-1213 to cell 
lysates from PEC-0 pre-incpbated without SM-1213 but re-
ceiving drug during NBT assay. When PEC-0 were pre-incu-
bated for 6 h in the presence or absence of SM-1213, sig-
nificant drug-induced enhancement of NBT reduction occurred 
in all drug-treated samples (Table IV). Pre-incubation of 
PEC-0 with drug resulted in an average percent increase in 
NBT reduction by cell lysates of 50.2% relative to cell 
lysates from PEC-0 pre-incubated in the absence of drug. 
Pre-incubation of PEC-0 without drug followed by incubation 
of cell lysates with drug during NBT assay resulted in an 
average percent increase in NBT reduction by cell lysates 
of 28.7% relative to cell lysates from PEC-0 pre-incubated 
in the absence of drug. When comparing NBT reduction by 
cell lysates from PEC-0 pre-incubated with SM-1213 to cell 
Table IV. NADPH-dependent reduction of NBT by cell lysates from oil-elicited PEC 
(PEC-0) 
nmoles NBT reduced710~ cells715 I m1n SM-1213 
concentration PEC-0 pre-incubated for: (% increase 
with vs. w/o (ng/ml) 6 h 6 h (% drug (% drug drug during 
with druga effect)£ w/o drug£ effect)b pre-incubation)d 
0 58.59 ± 1.12e 55.80 ± 2.79 (50 0) 
0.1 87.05 ± 3.9l*f (48.6) 69.75 ± 3.91* (25.0) (24. 8) 
1.0 88.72 ± 3.91* (51. 4) 75.33 ± 6.70* (35.0) ( 17. 8) 
10.0 88.16 ± 5.02* (50. 5) 70.31 ± 3.91* (26.0) (25.4) 
Average (50.2) (28.7) (22.7) 
a) PEC-0 were pre-incubated with the designated concentrations of SM-1213 for 6 h and 
washed to remove residual drug prior to stimulation with opsonized zymosan and cell 
lysis. Cell lysates were assayed for NBT reduction as described in Methods section. 
b) % drug effect = nmoles NBT reduced b :dru -treated - control(O n ml) sam les X 100 
nmoles NBT reduced by control (0 ng ml samples · 
c) PEC-0 from the same cell source as in a) were pre-incubated in the absence of drug 
for 6 h prior to stimulation with opsonized zymosan and cell lysis. Cell lysates 
were assayed for NBT reduction in the presence of the designated concentrations of 
SM-1213 as described in Methods section. 
d) % increase = nmoles NBT reduced by: a) - c) X lOO. 
nmoles NBT reduced by c) 
e) Mean ± SEM of triplicate dishes from one representative experiment. 
f) An asterisk (*) denotes P < 0.05 between untreated PEC (0 ng/ml) and 
drug-treated PEC samples. 
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lysates treated with drug during NBT assay only, NBT re-
duction was increased an average of 22.7% in cell lysates 
from PEC-0 pre-incubated with drug (Table IV). No sig-
nificant drug enhancement of NBT reduction was observed 
for either type of cell lysate after pre-incubation for 
less than 6 h (i.e., 2 h with drug: 0 ng/ml, 62.50 ± 1.00; 
0.1 ng/ml, 68.08 ± 3.08; 1.0 ng/ml, 61.38 ± 1.42. 2 h w/o 
drug: 0 ng/ml, 62.50 ± 1.12; 0.1 ng/ml, 65.29 ± 3.35; 
1.0 ng/ml, 64.17 ± 2.23). 
When resident PEC were tested in the same manner, 
no significant drug-enhanced 02 production was observed in 
either cell lysate type after either 2 or 6 h of pre-
incubation (Table V). NBT reduction was greater in oil-
elicited PEC lysates (Table IV) relative to cell lysates 
from resident PEC (Table V) , an effect which was most pro-
nounced in lysates from PEC pre-incubated for 6 h (cell 
lysates from PEC-0 pre-incubated in the absence of drug 
were increased an average of 19.7%, while cell lysates 
treated with drug during NBT assay or cell lysates from 
PEC-0 pre-incubated in the presence of drug were increased 
an average of 82.9%). 
J. Effect of SM-1213 Pre-incubation of PEC-0 on Hydrogen 
Peroxide Generation 
The results presented thus far suggest that SM-1213 
treatment of PEC-0 or of PEC-0 lysates induces an increase 
Table v. NADPH-dependent reduction of NBT by cell lysates from resident PEC 
(PEC-r) 
nmoles NBT reduced/10 6 cells/15 min 
SM-1213 
concentration 
(ng/ml) 
0 
0.1 
1.0 
2 h 
with drug~ 
PEC-r pre-incubated for: 
6 h 
with drug~ 
Experiment #1 
59 • 8 6 ± 1. 55.£ 55.21 ± 3.10 
54.70 ± 0.52 47.99 ± 3.10 
53.15 ± 2.06 47.99 ± 1.55 
6 h 
w/o drugb 
Experiment #2 
41.85 ± 2.79 
45.20 ± 1.67 
35.71 ± 2.23 
a) PEC-r were pre-incubated with the designated concentrations of SM-1213 for 2 
or 6 h and washed to remove residual drug prior to cell lysis. Cell lysates 
were assayed for NBT reduction as described in Methods section. 
b) PEC-r were pre-incubated in the absence of drug for 6 h prior to cell lysis. 
Cell lysates were assayed for NBT reduction in the presence of SM-1213 as 
described in Methods section. 
c) Mean ± SEM of duplicate or triplicate dishes. 
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in 02 production by enhancing the activity of phagocyte 
NAD(P}H oxidase. It follows that H20 2 generation would· 
also be increased by SM-1213 treatment of PEC-0, since 
dismutation of 02 produced by phagocytes results in the 
production of H20 2 (104}. It was decided to examine H2 0 2 
generation by SM-1213-treated PEC-0, since the production 
of this active oxygen species by phagocytes has been shown 
to be involved in the tumoricidal (92,97}, as well as the 
microbicidal (87,95,118}, activity of phagocytes. In 
addition, the possible modulation of phagocyte H20 2 pro-
duction by another related immunomodulatory drug, muramyl 
dipeptide (MOP}, was assessed, since this agent increases 
the NAD(P}H oxidase activity of phagocytes (51}. 
PEC-0 were pre-incubated for 2 or 6 h in the pres-
ence of SM-1213 or MOP, washed to remove residual drug, 
stimulated with opsonized zymosan, and assayed for extra-
cellular H20 2 production by the oxidation of phenol red. 
Extracellular H20 2 production by phagocytes was enhanced 
by pre-incubation for 2 h with 1 ng/ml of either drug and 
by pre-incubation for 6 h with 0.1 ng MDP/ml or 1 ng SM-
1213/ml (Figure 10}. 
H20 2 production by cell lysates, assessed by the 
oxidation of phenol red after disruption of PEC-0 with 
detergent, was significantly increased in samples treated 
with either drug at all concentrations tested (Figure 11}. 
Figure 10. The effect of SM-1213 pre-incubation of PEC-0 on extracellular 
H202 production during phagocytosis of opsonized zymosan. PEC-0 were pre-incubated 
for 2 or 6 h with the designated concentrations of SM-1213, washed to remove resid-
ual drug, and adherent PEC-0 were exposed to the phenol red assay system with 
opsonized zymosan as phagocytic stimulus. After incubation for 30 min, medium was 
assessed for extracellular H20 2 production as described in Methods section. Data 
represent means ± SEM of triplicate dishes and were derived from one representative 
experiment. An asterisk (*) denoted P < 0.05 between samples from PEC-0 pre-
incubated in the absence of drug and those from PEC-0 pre-incubated in the presence 
of drug. 
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Figure 11. The effect of SM-1213 pre-incubation of PEC-0 on cell lysate 
H20 2 production following phagocytosis of opsonized zymosan. Experimental con-
ditions were as in Figure 10, except PEC-0 were lysed with detergent following 
ingestion of opsonized zymosan and exposed to the phenol red assay system. Cell 
lysates were assessed for H20 2 production as described in Methods section. Data 
represent means ± SEM of triplicate dishes and were derived from one experiment. 
An asterisk (*} denotes P < 0.05 between samples from PEC-0 pre-incubated in the 
absence of drug and those from PEC-0 pre-incubated in the presence of drug. 
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In samples from PEC-0 pre-incubated for 6 h in the 
absence of drug, 85.7% of the total H2o2 produced by phago-
cytes was extracellular, while 14.3% was produced by cell 
lysates. In contrast, in all samples from PEC-0 pre-
incubated for 6 h in the presence of drug (MDP or SM-1213} , 
an average of 56.4% of the total H20 2 produced was extra-
cellular (range 47.1-66.1%}, while 43.6% was produced by 
cell lysates (range 33.9-52.9%}. While extracellular H20 2 
production either increased or decreased between 2 and 6 h, 
H20 2 production by cell lysates increased in all drug-
treated samples an average of 30% during this interval 
(Figures 10 and 11}. H2o2 ;production by samples from 
PEC-0 pre-incubated in the absence of drug remained un-
changed over time (Figure 11}. 
The addition of catalase to the H202 assay mixture 
resulted in a 94.6% reduction in phenol red oxidation, 
while boiled catalase reduced oxidation by 31.6% and SOD 
increased oxidation by 26%. 
K. Effect of SM-1213 on the Candidacidal Activity of the 
NADPH-NAD(P}H Oxidase System 
Since SM-1213 treatment enhanced the NADPH-depen-
dent production of 02 by PEC-0 1ysates (Figure 9), it was 
decided to examine the effect of SM-1213 on the NADPH-
dependent candidacida1 activity of PEC-0 homogenates. 
PEC-0 were pre-incubated in vitro for 2 or 6 h in 
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the absence of drug, stimulated with opsonized zymosan and 
homogenized. Cell homogenates were tested for SOD-inhibit-
able, NADPH-dependent candidal killing in the presence or 
absence of SM-1213. The results are depicted in Figure 12. 
Significant drug-induced enhancement of SOD-inhibitable 
candidal killing was observed by cell homogenates from 
PEC-0 pre-incubated for 2 or 6 h in the absence of drug 
and subsequently treated with 0.1 or 1 ng SM-1213/ml during 
the killing assay (Figure 12). Cell homogenates from PEC-0 
pre-incubated for 6 h in the absence of drug and subse-
quently treated with 10 ng SM-1213/ml also demonstrated 
enhanced candidal killing. ; When cell homogenates were 
boiled before addition to Candida or when no NADPH was 
added to the incubation mixture, some killing was observed 
(Figure 12). SM-1213 did not enhance killing by boiled 
cell homogenates or by samples receiving no NADPH. 
The enhanced killing of Candida by drug-treated 
cell homogenates was not an artifact resulting from the 
increased clumping or sticking together of yeast cells in 
the presence of drug as determined by phase contrast micros-
copy. 
Candidal killing by cell homogenates in the pres-
ence or absence of SM-1213 was also assessed by the meth-
ylene blue dye exclusion technique (63). Although overall 
candidacidal activity in all samples was lower (4-17.5% 
Figure 12. The effect of SM-1213 on NADPH-dependent candida! killing by 
cell homogenates. PEC-0 were pre-incubated in vitro for 2 or 6 h in the absence 
of drug prior to stimulation with opsonized zymosan and cell homogenization. 
Candida yeast cells were incubated with cell homogenates and substrate NADPH for 
90 min in the absence or presence of the designated concentrations of SM-1213. 
After incubation, serial dilutions of samples were plated on SDA for enumeration 
of cfu 48 h later. Cell homogenates from PEC-0 pre-incubated in the absence of 
drug and receiving no NADPH during incubation are designated below as NO NADPH. 
Cell homogenates which were boiled for 10 min before incubation with Candida in 
the assay system are designated below as BL. Data represent the mean percent 
SOD-inhibitable Candida killed relat~ve to Candida incubated in buffer alone 
from duplicate d~shes ± SEM and were derived from one experiment. An asterisk 
(*) denotes P < 0.05 between drug-treated and untreated (0 ng/ml) samples. 
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dead), the enhancement of candidal killing by drug-treated 
cell homogenates or cell lysates (lysed with 0.5% NI) was 
evident using this assay system (P < 0.05). The methylene 
blue assay system may, however, have given artificially 
high values for the number of apparently viable Candida. 
For example, others have demonstrated that as many as 27% 
of Candida killed by activated mouse macrophages (as assay-
ed by microcolony formation) did not lose their ability to 
exclude dye during the assay period (45). 
CHAPTER IV 
DISCUSSION 
In the absence of PEC, SM-1213 had no direct fungi-
static or fungicidal effect against the yeast or hyphal 
form of Candida albicans (Table I). However, SM-1213 was 
found to be effective in inducing PEC-0 to inhibit the 
intracellular formation and elongation of ~ albicans 
hyphae (Figure 2) and to reduce the percentage of viable 
Candida remaining after phagocytosis (Table II). Signif-
icant drug-induced candidastatic and candidacidal effects 
were also observed when PEC-o were pre-incubated with 
SM-1213 and washed prior to infection with Candida (Figure 
3, Table II). These results indicate that SM-1213 was 
able to potentiate one or more candidacidal processes 
expressed by PEC-0. 
When PEC-0 were infected and incubated with SM-
1213, the most significant drug-induced reductions in 
hyphal growth and candida! viability occurred at the 1 
ng/ml drug level (Figure 2, Table II). Higher or lower 
concentrations of drug were less effective, reflecting the 
bell-shaped dose response curve frequently observed for 
irnrnunomodulatory drugs (35,40). In addition, others (12) 
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have reported that SM-1213 enhanced the effectiveness of 
mouse resident peritoneal rnacrophages against Mycobacterium 
tuberculosis when macrophages were treated with SM-1213 
concentrations as low as 0.01 ng/ml and as high as 100 
ng/ml. However, the most effective antimycobacterial drug 
concentration examined by a dose response curve was 1 ng/ml 
(12). Also, Hadden ~ al (40) reported that SM-1213 was 
capable of significantly increasing the killing of intra-
cellular Listeria monocytogenes within oil-elicited guinea 
pig macrophages treated with the lowest SM-1213 concen-
tration tested, 0.12 ~g/ml. 
While PEC-0 treatea with 10 ng SM-1213/ml did not 
kill a greater percentage of Candida than untreated (0 
ng/ml) PEC-0 (Table II), intracellular inhibition of hyphal 
growth, although not significant, was suggested (Figure 2) 
and may reflect the initiation of hyphal injury. Hyphal 
inhibition was greatest relative to controls at 4 h, as 
opposed to at 6 h, in PEC-0 receiving lower drug concen-
trations (Figure 2) • It is not known at present whether 
SM-1213 is taken into and accumulated within PEC-0 over 
time. Although requested from Greenwich Pharmaceuticals, 
radiolabelled SM-1213 was not available at the time the 
present studies were conducted. If, however, SM-1213 was 
taken into and accumulated within PEC-0, then PEC-0 treated 
with 10 ng SM-1213/ml could attain effectively candida-
static drug levels at an earlier time interval (4 h) than 
PEC-0 treated with lower drug concentrations. The mild 
reduction in candidastatic action at 6 h relative to at 
4 h was not due to a toxic effect of SM-1213 upon phago-
cytes at the 10 ng/ml concentration for several reasons: 
1) uninfected PEC-0 incubated in the presence of SM-1213 
were >97% viable by trypan blue dye exclusion after 6 h 
in culture; 2) others have demonstrated that the anti-
bacterial activities of macrophages were significantly 
enhanced at this (12) or higher (40) drug concentrations; 
and 3) others have reported that drug concentrations 10-
1000 times higher did not ~ffect the viability of WI-38 
cells (37) or macrophage monolayers (40). 
The occurrence of maximal drug-induced effects at 
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6 h for PEC-0 treated with 0.1-1 ng SM-1213/ml suggests 
that modulation of PEC-0 anticandidal mechanisms are either 
initiated at an earlier time interval but enacted slowly 
(over 6 h) or not initiated until 6 h for reasons which 
may include the unresponsiveness of PEC-0 to drug action 
at earlier intervals or the accumulation or processing of 
drug by PEC-0, resulting in drug effectiveness at 6 h. 
Others have suggested that a small but sustained oxidative 
attack by phagocytes results in effective target cell 
injury and death over time (97,118). Upon phagocytosis of 
opsonized Candida, PEC-0 pre-incubated in the absence or 
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presence of drug were capable of producing as much or more 
Oi after 2 h in culture as after 6 h in culture (Figure~). 
PEC-0 pre-incubated in the presence of SM-1213 demonstrated 
enhanced 02 production at both time intervals relative to 
controls (Figure 5). These data suggest that SM-1213 can 
enhance the oxidative anticandidal mechanisms of PEC-0 
after only 2 h of drug treatment and that sustained oxi-
dative injury may be responsible for the observed candida-
static and candidacidal effects at 6 h. However, the 
effect of culturing PEC-0 over time may also influence 
candidacidal mechanisms and the modulation of these mech-
anisms by SM-1213. 
When PEC-0 were pre-incubated with SM-1213 for 
6 h and washed prior to infection, all drug levels tested 
induced significant and relatively similar anticandidal 
effects (Figure 3, Table II). It is not surprising that 
PEC-0 pre-incubated in the presence of drug prior to the 
introduction of an infectious agent were equally receptive 
to modification by all levels of drug rather than one or 
two levels as observed for PEC-0 exposed to drug at the 
time of infection (Figure 2, Table II). Other immune-
modulatory agents, such as MOP and LPS, are totally in-
effective stimulators of an enhanced oxidative response, 
unless phagocytes are pre-incubated with these agents for 
15 min to 4 h prior to the addition of a phagocytic or 
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chemical stimulus (51,100). Therefore, SM-1213 has the 
added capacity to enhance the candidacidal action of PEC-0 
when administered at the time of phagocyte infection (Fig-
ure 2, Table II). These actions can be related to in vivo 
effects as well, since MDP is most effective in enhancing 
the survival of mice infected intravenously with ~ ~­
cans when administered prophylactically 18 h prior to 
inoculation (23) while SM-1213 is most effective when drug 
is given 3 to 5 days after infection (83). 
The mechanism whereby SM-1213 enters into PEC-0 
pre-incubated in the presence of drug, as opposed to PEC-0 
exposed to drug during in~ection, may provide an explana-
tion for the observed differences in PEC-0 candidacidal 
effectiveness at the 10 ng/ml drug level. For example, 
PEC-0 pre-incubated in the presence of SM-1213 may use 
pinocytotic or sugar transfer mechanisms to transport 
SM-1213 into PEC-0. PEC-0 exposed to SM-1213 at the time 
of infection would also take drug into the phagocytic 
vacuole along with Candida cells. Within phagocytic vacu-
oles, the drug may be retained in high concentration and 
remain localized in this cellular compartment. 
Alternatively, during pre-incubation SM-1213 may 
not enter the cell, but may bind to the exterior of or 
induce a modification of the cell membrane. The lyrnpho-
kine, interferon-y, has been reported to be an effective 
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stimulator of macrophage reactive metabolite production 
when macrophages are exposed for as little as 10 min to. 
this agent, washed, and stimulated with PMA three days 
later (94). Therefore, the exposure of PEC-0 to SM-1213, 
followed by washing of the cells, may provide stimulation 
without subsequent inhibition of candidacidal mechanisms as 
a result of excess drug concentration. 
At the time of infection, pre-incubated PEC-0 were 
composed of an entirely adherent cell population, while non-
pre-incubated PEC-0 were composed of freshly plated adher-
ent and non-adherent cells. It was therefore conceivable 
that differences in PEC-0 qell types present or the state 
of cell adherence at the time of initial candida! infection 
caused differences in the observed candidacidal activity of 
pre-incubated versus non-pre-incubated PEC-0. However, 
this was probably not the case, since PEC-0 allowed to ad-
here to culture dishes for 2 h and washed prior to infection 
gave virtually identical results to those obtained for un-
separated PEC-0 (unpublished observation, c. J. Morrison). 
After 6 h of pre-incubation in the presence or 
absence of drug, only a 2 h incubation period was required 
for PEC-0 to kill percentages of Candida almost as great or 
greater than PEC-0 incubated with Candida for 6 h (Table 
II). This suggests that, once PEC-0 are primed by pre-
incubation in culture for 6 h, they become more effectively 
candidacidal upon presentation of the infecting micro-
organism. However, there is also evidence to indicate 
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that the candidacidal (59) and microbicidal (88) activities 
of phagocytes may actually be reduced by time in culture 
and, as depicted in Figure 5, upon stimulation with opson-
ized Candida the production of 02 by PEC-0 cultured for 
6 h was reduced relative to those cultured for 2 h. Since 
02 production by phagocytes has been correlated to their 
candidacidal activity (118), a reduced production of 02 at 
6 h should result in a reduced anticandidal capacity for 
PEC-0 at this time interval relative to at 2 h. Indeed, 
for PEC-0 pre-incubated in .the absence of drug, no 02 pro-
duction was observed at 6 h upon addition of opsonized 
Candida (Figure 5), although >97% of PEC-0 were viable. 
Whether this reduction at 6 h was due to a non-responsive-
ness of PEC-0 at this time interval or whether Candida 
actively "turned off" or failed to initiate 02 production 
by these cells is not known. However, PEC-0 pre-incubated 
in the absence of drug were able to respond oxidatively at 
6 h when opsonized zymosan was used as the phagocytic 
stimulus (Figures 6 and 7), although the response was 
somewhat reduced relative to at 2 h. This indicates that 
PEC-0 were less responsive to ~ albicans than to zymosan 
at 6 h due to an inherent property of the microbe. 
Others have demonstrated that, although two candidal 
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species were phagocytosed equally, ~ albicans stimulated 
only half the quantity of 02 production by macrophages as 
the less virulent species, ~ parapsilosis (118). Also, 
the survival of the intracellular pathogen, Toxoplasma 
gondii, within human macrophages was reported to be the 
result of ingestion of the organism without a stimulation 
of the production of reactive oxygen intermediates (127). 
Similarly, in studies presented here, PEC-0 pre-incubated 
in the absence of drug phagocytosed opsonized Candida 
normally at 6 h (unpublished observation, C. J. Morrison), 
although no stimulation of phagocyte o; production was 
detected. 
The ability of opsonized Candida to stimulate 02 
production by control PEC-0, pre-incubated in the absence 
of drug for 2 h, may relate to a state of PEC-0 "pseudo-
activation" as a result of agitation during cell harvesting 
and plating. Activated macrophages have been shown to 
generate increased amounts of reactive oxygen metabolites 
upon phagocytosis of Candida (118), and thus the 2 h pseudo-
activation of phagocytes might result in a priming of 
control PEC-0 for an enhanced oxidative response upon 
stimulation with Candida. It is hypothesized that, after 
6 h in culture, the initial pseudo-activation of PEC-0 
would diminish so that opsonized Candida would no longer 
stimulate an oxidative response. Cultured human macro-
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phages have been reported by others (86,94) to gradually 
lose H20 2-producing capacity with time in culture, while 
resident mouse macrophages have been reported to gradually 
increase this capacity over a 72-h period (87). Others 
have reported an increase followed by a decrease in H2 o2-
producing capacity for human macrophages (89). 
Results of studies with monocytes from a patient 
with X-linked CGD and his heterozygous mother were reported 
to indicate that oxygen-dependent mechanisms were important 
to the early and efficient killing of ~ gondii, but that 
non-oxidative reserve mechanisms which were less efficient 
were capable of killing this microbe (127). Similar re-
sults were reported for the killing of Leishmania donovani 
by CGD monocytes and, upon exposure to lymphokines, CGD 
macrophages (86). The observed killing of Candida at 6 h 
by PEC-0 pre-incubated in the absence of drug (Table II) 
without detectable 02 production (Figure 5) may, therefore, 
be due to the non-oxidative killing mechanisms of phago-
cytes. PEC-0 pre-incubated in the presence of drug demon-
strated a reduced but substantial production of 02 at 6 h 
relative to at 2 h (Figure 5). Drug-treated PEC-0 may 
therefore utilize both oxidative and non-oxidative killing 
mechanisms, resulting in the observed overall enhancement 
of candidal killing for drug-treated PEC-0 relative to 
control PEC-0 (Table II). 
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Candida cells may also possess protective mechan-
isms whereby they "turn off" the anticandidal systems o~ 
macrophages. Ozato and Uesaka (99) observed that intra-
cellular candida! growth was temporarily inhibited by 
casein-elicited macrophages but, after 2-3 h, candida! 
growth resumed, resulting in the outgrowth and survival of 
Candida cells. The production of endogenous scavengers of 
reactive oxygen metabolites such as catalase or superoxide 
dismutase (SOD) may be induced in microorganisms exposed 
to high oxygen tensions (38). Therefore, Candida ~ay 
interfere with the anticandidal capacities of macrophages 
via the production of thes~ enzymes. As detailed in the 
introduction to this .paper, candida! catalase or SOD in 
and of itself may not be sufficient to protect fungi from 
damage by external oxygen metabolites (118). However, the 
exogenous addition of catalase or SOD to macrophages in-
gesting Candida can inhibit phagocyte candidacidal activity 
(118) and, in conjunction with PMN (77) or macrophages 
(88), microbial or phagocyte catalase may antagonize phago-
cyte-mediated killing. For example, Murray !! al (88) 
reported an increase in intracellular macrophage catalase 
activity with time in culture that was associated with a 
decreased ability of phagocytes to kill ~ gondii. In 
studies concerning the effect of SM-1213 on PEC-0 catalase 
activity, no increase in phagocyte catalase activity was 
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observed for resident or oil-elicited PEC between 2 and 
6 h of culture (unpublished observation, c. J. Morrison). 
Although no increase in catalase activity was observed 
over time, control (0 ng/ml) PEC-0 demonstrated a 1.5-fold 
greater catalase activity when infected relative to un-
infected PEC-0 (Table III). This suggests that, after 
phagocytes produce reactive oxygen metabolites in response 
to an infectious agent, PEC-0 initiate an enhanced endo-
genous production of catalase to protect against auto-
oxidative damage (112). As a result, phagocytes may reduce 
their own antimicrobial effectiveness or the antimicrobial 
effectiveness of neighboring phagocytes upon autolysis and 
release of endogenous catalase. In Y!!2, however, infec-
tions may be resolved as a result of the sequential rein-
forcement or renewal of phagocytes induced by cellular 
immunity (82) or the release of inflammatory mediators 
( 12 4) • 
Another possible explanation for the moderately 
higher catalase activities in the infected versus unin-
fected PEC-0 may be due to a contribution of catalase 
activity from ~ albicans cells. Sasada and Johnston (118) 
suggested that intracandidal SOD or catalase did not affect 
the level of detectable 02 produced by macrophages, since 
intact, viable Candida showed no detectable release of 
these enzymes. Upon sonication, however, substantial 
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candidal catalase (320 U per mg protein) and SOD (21.8 U 
per mg protein) activity was detected (118). It is there-
fore plausible that killing of candidal cells by PEC-0 
could result in some leakage of intrafungal catalase. 
However, it is unlikely that this is the case, since: 1) 
SM-1213-treated PEC-0, which killed more Candida, did not 
demonstrate greater catalase activity after cell lysis 
than cell lysates from control PEC-0 (Table III); 2) the 
increased catalase activity of infected PEC-0 was selective 
in that no other enzyme activities tested were increased 
(unpublished observation, c. J. Morrison, and Table III), 
including enzymes comrnonlyi found in fungi (21,119); and 
3) infected PEC-0 lysates did not contain more protein 
than cell lysates from uninfected PEC-0. 
Since an increase in phagocyte catalase activity 
has been correlated to a reduced microbicidal capacity 
(88), the observed reduced capacity of control PEC-0 to 
kill c. albicans cells (Table II) relative to drug-treated 
PEC-0 may be the result of not only a relatively reduced 
production of reactive oxygen metabolites (Figures 5,6,7, 
10,11), but a relatively greater production of catalase 
(Figure 4, Table III) by control PEC-0. It has been re-
ported by others (57) that 02 can interfere with the heme 
portion of the catalase molecule and, as a result, inhibit 
its activity. It may be, then, that the reduction in 
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catalase activity observed for drug-treated PEC-0 (Figure 
4) is the result of the increased production of 02 by these 
cells (Figures 5,6,7). 
Resident PEC catalase activities were unaffected 
by drug treatment, suggesting that the physiological state 
or the state of differentiation of PEC affects PEC respon-
siveness to drug modulation. For example, elicited cells 
contain a larger proportion of more newly recruited cells 
(monocytes) than resident cells, which consist predomin-
antly of established cells (macrophages) (42). Upon presen-
tation with a phagocytic or chemical stimulus, macrophages 
from uninflamed tissues sedrete little 02 or H2o2 (49,96), 
while cells primed by exposure to inflammatory agents or 
lymphocyte mediators secrete high levels of these agents 
(49,87). Therefore, a similar mechanism of PEC priming 
may be necessary before maximum SM-1213-induced effects 
are invoked. As reported for MDP (23), SM-1213 adminis-
tered in vivo can also modulate PEC activities in vitro. 
PEC-0, obtained on day three from guinea pigs treated 
intramuscularly with 10 mg SM-1213 per kg per day for 
three days, demonstrated a significant reduction in cata-
lase activity in vitro relative to PEC-0 from animals 
which did not receive drug (unpublished observation, c. J. 
Morrison). In addition, significant drug-induced reduc-
tions in catalase activity were observed in lysates of the 
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phagosomal fraction of homogenized guinea pig PEC-0 treated 
with 1 ng SM-1213/ml (P. Gordon, personal communication). 
Thus, enhanced intraphagosomal killing of Candida may 
result from a reduced catalase activity (or enhanced 02 
production?) at this site due to drug treatment of PEC-0. 
Although reduced, cytosolic catalase activity may remain 
sufficiently active to protect PEC from auto-destruction 
due to the leakage of reactive oxygen products from the 
phagosomal compartment (112). 
The ratio of cell-associated to extracellular 02 
and H202 produced was significantly increased in SM-1213-
treated PEC-0 relative to' control PEC-0. In control PEC-0, 
only 0 to 14% of total oxidative metabolites were cell-
associated, while, in drug-treated PEC-0, 34 to 44% were 
cell-associated. Therefore, if oxidative candidacidal 
mechanisms are initiated intraphagosomally or intracellu-
larly, drug-treated PEC-0 would be expected to kill a 
greater percentage of phagocytosed Candida than untreated 
PEC-0. Also, since 100% of 02 and 86% of H2o2 produced by 
control PEC-0 were.extracellular, not only would intra-
cellular candidal killing be reduced in these cells, but 
oxidative damage to surrounding tissues (116) and phago-
cytes (112) would be increased. The anticandidal and 
anti-inflammatory effects of SM-1213 have been demonstrated 
in vivo where intramuscularly infected mice treated with 
SM-1213 produced smaller candida! abscesses relative to 
control mice without a concomitant reduction in candida-
cidal activity (83). 
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Since SOD is a particularly efficient inhibitor of 
candidacidal activity, others have suggested that 02 may 
be an especially important reactive oxygen metabolite in 
phagocyte anticandidal activity (118). However, several 
researchers have suggested that H2o2 is the oxidative agent 
primarily responsible for phagocyte tumoricidal (92,97) 
and microbicidal (86,95) activity. Both SM-1213 and the 
structurally related (Figure 1) immunomodulatory drug, MOP, 
effectively enhanced totaliH20 2 production by PEC-0 (Fig-
ures 10 and 11) . This enhancement was evident at 2 and at 
6 h. H2o2 production increased between 2 and 6 h by an 
average of 30% for PEC-0 pre-incubated in the presence of 
drug, while H2 o2 production remained unchanged over time 
for PEC-0 pre-incubated in the absence of drug (Figures 10 
and 11). The increase in H2o2 production between 2 and 6 h 
correlates with the decrease in detectable 02 produced 
during this time interval (Figures 5,6,7). This suggests 
that a greater quantity of 02 is being converted into H2o2 
(reducing detectable 02 levels) at 6 h than at 2 h in drug-
treated PEC-0. These observations would provide an explan-
ation for the reduced production of 02 over time in culture 
while PEC-0 viability was intact. However, this explana-
tion is relevant to drug-treated PEC-0 only, since no 
increase in H2o2 production over time was observed for 
control PEC-0 (Figures 10 and 11) • Not all 02 produced 
was spontaneously dismutated to H2o2, however, since the 
addition of SOD to the assay system increased detectable 
H202 production by 26%. 
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In addition to significantly increasing the pro-
duction of active oxygen species by phagocytes, SM-1213 
and MDP can significantly enhance the candidacidal and 
candidastatic activity of a cell-free xanthine-xanthine 
oxidase (115) 02-generating system (unpublished observa-
tions, c. J. Morrison). Complete protection of Candida 
from growth inhibition occurred when SOD was included in 
the system and substantial (83%) protection occurred when 
catalase was included. Therefore, 02 and H20 2 were impor-
tant mediators of the anticandidal activity of this system. 
Scavengers of •OH and singlet oxygen did not protect Can-
dida. Preliminary experiments indicate that SM-1213 can 
enhance the binding of xanthine oxidase to Candida, resul-
ting in an enhanced killing capacity which may be due to 
the closer proximity of the 02-producing machinery to the 
target cell. Others (130) have reported that binding of 
myeloperoxidase (MPO) to Candida cells is required for MPO-
mediated killing of fungi and bound eosinophil peroxidase 
(EPO) has been demonstrated to effectively enhance the 
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microbicidal activity of EPO-mediated killing of T. gondii 
( 70) • 
It has been reported that soluble cell wall mannans 
bind to myeloperoxidase (MPO), and thereby competitively 
inhibit MPO-mediated killing of Candida in a dose-dependent 
manner (130). In addition, soluble candidal mannans demon-
strated a similar dose-dependent inhibitory effect on 
neutrophil-mediated candidacidal activity (130). In macro-
phages, which may or may not contain peroxidase activity 
(9,22,25), it could be speculated that soluble cell wall 
mannans may act as competitive inhibitors for the interac-
tion or binding of the 02-producing NAD(P)H oxidase. This 
would be especially important if close proximity or binding 
of the NAD(P)H oxidase to the target cell was required for 
NAD(P)H oxidase-mediated candidal killing, as binding is 
required for MPO-mediated candidacidal activity (130). 
Such binding would allow for the generation of short-lived 
02 in close proximity to the target cells, so as to in-
crease the probability that the microorganism would become 
substrate for this reactive product and others (130). 
Alternatively, the action of NAD(P)H oxidase may be 
"turned off" by the binding of soluble cell wall mannans. 
This hypothesis would explain the observed absence of 02 
production at 6 h by untreated PEC stimulated with opson-
ized Candida (Figure 5), but would not explain the lack of 
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an inhibitory effect at 2 h. In addition, zymosan, derived 
from cell wall components of the yeast Saccharomyces ~­
visiae and composed largely of mannan (5), is a potent 
stimulator of phagocyte oxidative responses when presented 
in the opsonized form (49,104) and to a lesser extent in 
the unopsonized form (26). Also, mannans have been repor-
ted to enhance H2 0 2 production by PMN, while mannose in-
hibited its production (26). It is likely, then, that 
candidal mannans "turn on" the NAD(P)H oxidase, rather than 
turning it off. 
Since the oxidative responses of phagocytes can be 
stimulated by a number of;soluble agents (92,104,113), the 
initiation of the metabolic burst has been reported to 
occur at the plasma membrane (43,90). Molecules which can 
stimulate the oxidative burst, such as concanavalin A 
(Con A) (110) , are reported to bind to mannose residues of 
phagocyte plasma membrane glycoproteins, resulting in a 
perturbation that invokes the oxidative burst (104). It 
has been proposed by others (26) that the stimulation of 
the oxidative burst of PMN upon presentation with ~ albi-
~ blastospores involves a receptor-ligand interaction 
at the plasma membrane. This hypothesis was based on a 
mannose-specific mechanism, since oxidative stimulation by 
Candida (but not by PMA or opsonized Sephadex) could be 
competitively inhibited upon the addition of mannose (26). 
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Since the NAD(P)H oxidase of phagocytes resides in the 
plasma membrane (8,91), either it or glycoproteins associ-
ated with it may be cross-linked by the binding of C. 
albicans or fungal cell wall components. Therefore, ·binding 
of Candida to the NAD(P)H oxidase may be required for the 
initiation of the oxidative burst and the subsequent kill-
ing of Candida by phagocytes via locally produced oxygen 
metabolites. 
However, binding of Candida to the membrane may 
not be sufficient for maximal activation of the NAD(P)H 
oxidase. For example, the stimulation of the oxidative 
burst by Con A will not occur unless this agent is in the 
tetrameric form (104). Also, phytohemagglutinin (PHA), 
soybean agglutinin (SBA) and Lotus lectin all bind to 
macrophages (39), but do not stimulate 02 production (104). 
Therefore, the configuration of the stimulating agent, as 
well as its binding to phagocytes, influences oxidative 
responsiveness. This was evident in studies conducted here 
in that opsonized Candida did not stimulate 02 production 
by PEC-0 after 6 h in culture unless PEC-0 had been pre-
incubated in the presence of SM-1213 (Figure 5). Opson-
ized zymosan, however, could stimulate 02 production at 
6 h by control PEC-0 (Figures 6 and 7) and SM-1213 pre-
treatment of PEC-0 enhanced this production. Thus, even 
though zymosan and Candida contain mannan and/or mannose, 
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the manner in which they interact at the plasma membrane 
level differs somewhat. Similarly, the greater resistance 
of ~ albicans to macrophage killing relative to other 
species has been suggested to result from the less favor-
able stimulation of the respiratory burst enzyme in the 
plasma membrane by ~ albicans (118). 
Since pre-incubation of PEC-0 with SM-1213 enhances 
the subsequent stimulation of PEC-0 oxidative metabolism 
upon the addition of either zymosan or Candida (Figures 5, 
6,7), its actions may involve: 1) interacting with or 
alteration of the plasma membrane or the membrane oxidase; 
2) changing the configuration of the stimulating agent; 
3) changing the configuration of opsonins or the response 
of PEC-0 to opsonins; or 4) enhancing the binding of stim-
ulating agents to the membrane. SM-1213 may enhance the 
binding of Candida to the membrane oxidase in a manner 
similar to that proposed by Wright !! al (130) for the 
binding of MPO to Candida. It was suggested (130) that the 
binding of MPO to Candida was facilitated by electrostatic 
forces, since MPO is a cationic enzyme and the surface of 
Candida is anionic. Similarly, the alkylaminoalkyl sub-
stitution of SM-1213 is cationic at physiological pH (P. 
Gordon, personal communication) and may serve to bind SM-
1213 to candidal surfaces. Drug treatment may thereby 
change the surface of Candida so that the manner in which 
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fungi are presented to PEC-0 or are bound by PEC-0 is 
altered. Experiments conducted on the NADPH-dependent 
production of 02 by cell lysates revealed that, in the 
absence of Candida, SM-1213 could enhance NADPH-dependent 
02 production (Figures 8 and 9, Table IV). Therefore, 
although candidal binding, candidal configuration, or 
opsonic configuration may be influenced by drug, the activ-
ity of the NAD(P)H oxidase enzyme or the membrane in which 
it is located is altered by SM-1213 treatment as well. 
However, opsonins would probably not be affected, since 
the enhanced killing of Candida by drug-treated PEC-0 
occurred in their absence (Table II). 
The NADPH-NAD(P)H oxidase system of PEC-0 was 
directly modified by SM-1213 treatment (Table IV). Super-
oxide anion production by cell lysates was enhanced an 
average of 28.7% in the presence of drug, and this enhance-
ment was increased to 50.2% if PEC-0 were pre-incubated 
with drug prior to cell lysis (Table IV). 
Drug-enhanced NADPH-dependent 02 production by cell 
lysates was time dependent (Figures 8 and 9) and was not 
apparent until the 6 h time interval. This was the case 
whether PEC-0 were pre-incubated with drug prior to lysis 
(Figures 8 and 9) or pre-incubated without drug and exposed 
to SM-1213 during the time of NBT assay only (Table IV) • 
Therefore, PEC-0 become more receptive to drug modification 
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with time in culture. Indeed, unlike 02 production by 
whole PEC-0, 02 production by cell lysates was enhanced at 
6 h relative to at earlier time intervals (Figure 9}. The 
reduced activity at 0 h may have resulted from the presence 
of contaminating red blood cells which contain SOD (75}. 
Pre-incubation of PEC-0 with drug prior to cell lysis in-
creased 02 production by cell lysates an average of 22.7% 
relative to cell lysates treated with drug during NBT assay 
only. Thus, pre-treatment of PEC-0 with drug, as well as 
incubation of PEC-0 in culture, primes phagocytes to pro-
duce greater quantities of 02. 
The significantly ~igher quantities of 02 produced 
by cell lysates (Figure 9} relative to whole PEC-0 (Figure 
6} may relate to the availability of the 02-producing 
enzyme to activation. Although located in the plasma mem-
brane (8}, NAD(P}H oxidase, once liberated by cell lysis, 
may have more access to activation by substrate. Also, the 
exogenous addition of substrate in excess may allow for a 
more complete expression of enzyme activity. Others have 
reported (SO} an increased production of 02 by cell lysates 
relative to intact phagocytes, particularly in phagocytes 
from patients with CGD. Intact CGD phagocytes were marked-
ly deficient in 02 production, while cell lysates from CGD 
phagocytes were only mildly deficient (50}. It was sug-
gested that the enzyme or enzymes controlling 02 production 
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were present within CGD phagocytes, but that they were not 
strategically placedl or not fully activated upon stimulq-
tion with a phagocy~ic particle (50). 
NADPH-dependlent 02 production by cell lysates from 
resident PEC was no~ affected by SM-1213 treatment (Table 
V). Also, the quan~ities of 02 produced by PEC-r lysates 
were generally lower than for PEC-0 lysates (Figure 9, Table 
IV and V) • The basi_ s for these differences between resi-
dent and oil-elicite~d cell lysates may relate to the char-
acter of each of the:Se cell types. The resident cells of 
the peritoneal cavit_y, which are primarily mature macro-
phages, have been sh own by bthers (6) to differ from newly 
recruited inflammato•rY cell types, which are primarily 
monocytes. The matu ration of mononuclear phagocytes into 
macrophages is assoc iated with alterations of plasma mem-
brane proteins, ecto-enzyme activity, and surface receptor 
expression (17,18). Although not readily apparent in our 
studies, differences in cell size (18) may also account for 
differences in the reelative 02-producing capacities of 
PEC-r and PEC-0. Th•erefore, as mentioned earlier in refer-
ence to the modulati•On of PEC catalase activity, the physi-
ological state and tihe state of differentiation of PEC can 
influence phagocyte :functions and, in this instance, the 
02-producing capacit=Y of PEC and the modulation of this 
capacity by SM-1213. 
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The significant relationship between the drug-
enhanced production of PEC-0 reactive oxygen metabolites 
and the increased killing of Candida by drug-treated phago-
cytes was demonstrated upon incubation of Candida with an 
NADPH-cell homogenate derived NAD(P)H oxidase system (Fig-
ure 12). SM-1213 enhanced the candidacidal capacity of 
this enzyme system. The mechanism for this enhancement is 
not known, but data from experiments previously discussed 
using cell lysates (Figure 9, Table IV) suggest that SM-
1213 can directly enhance the Oz-producing capacity of 
phagocyte NAD(P)H oxidase. Experiments are underway to 
determine if SM-1213 can also enhance the binding of Can-
dida to NAD(P)H oxidase, and thereby enhance candidal 
killing upon addition of NADPH. Since 50-88% of candidal 
killing by this system was inhibitable by SOD, the reactive 
oxygen intermediate responsible for candidacidal activity 
was most probably Oz. However, not all killing was due to 
oxidative mechanisms, since some killing occurred in the 
absence of substrate NADPH and when cell homogenates were 
boiled prior to addition to the system (Figure 12). Since 
cell homogenates were utilized and not purified enzymes, 
killing resulting from exposure of Candida to homogenates 
may be due in part to non-oxidative candidal killing by 
components derived from phagocyte lysosomal compartments 
(i.e., cationic proteins) or other toxic agents, and is 
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therefore an artifact of this system. NADPH-dependent 
killing is presumed to represent oxidative cytocidal mech-
anisms. Therefore, an examination of the NADPH-independent 
and NADPH-dependent killing of Candida revealed that the 
majority of candidal killing by control cell homogenates 
was NADPH-independent (non-oxidative) , while the greater 
portion of candidal killing by drug-treated cell homogen-
ates was NADPH-dependent (oxidative) (Figure 12). In whole 
PEC-0, however, the proportion of oxidative to non-oxida-
tive candidal killing may be much greater since, in cell 
homogenates, a bolus of non-oxidative hydrolytic and de-
gradative enzymes, as wellias candidacidal cationic pro-
teins (66), may be released upon phagocyte lysis. 
In conclusion, SM-1213 treatment of PEC-0 was 
observed to inhibit the growth and reduce the viability of 
intracellular Candida cells, as well as to enhance the 
production of PEC-0 oxidative metabolites, hydrogen perox-
ide and superoxide anion. The enhanced NADPH-dependent 02 
production by phagocytes treated with SM-1213 and by cell 
lysates treated with SM-1213 at the time of assay indicate 
that the observed enhanced production of oxidative metabo-
lites results from an increased activation of PEC-0 NAD(P)H 
oxidase, the enzyme responsible for the production of 
reactive oxygen species by phagocytes (8,91). The role of 
oxygen metabolites in the candidacidal activity of phage-
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cytes has been established by others (62,118), and the 
modulation of NAD(P)H oxidase activity by SM-1213, resul-
ting in a concomitant increased production of these agents, 
was supported by the enhanced candidacidal action of the 
NADPH-NAD(P)H oxidase system in the presence of SM-1213. 
SUMMARY 
SM-1213 [1,2-0-isopropylidene-3-0-3'-(N' ,N'-dimeth-
ylarnino-n-propyl)-D-glucofuranose] is a synthetic, substi-
tuted monosaccharide which exerts immunomodulatory actions. 
In the absence of PEC, SM-1213 had no direct fungistatic or 
fungicidal effect against the yeast or hypha! form of 
Candida albicans, a clinically important opportunistic 
fungus. However, SM-1213 was effective in inducing PEC-0 
to inhibit the intracellular formation and elongation of 
c. albicans hyphae and to reduce the percentage of viable 
Candida remaining after phagocytosis. Significant drug-
induced candidastatic and candidacidal effects were also 
observed when PEC-0 were pre-incubated in the presence of 
SM-1213 and washed prior to infection with Candida. These 
results indicate that SM-1213 was able to potentiate one or 
more candidacidal processes expressed by PEC-0. Pre-incu-
bation of PEC-0 with SM-1213 prior to introduction of a 
phagocytic stimulus resulted in an enhanced production of 
both hydrogen peroxide and superoxide anion. In addition, 
incubation of PEC-0 with SM-1213 for 6 h resulted in a 
selective reduction in adherent cell catalase activity 
relative to control PEC-0. NADPH-dependent production of 
superoxide anion was enhanced in cell lysates from PEC-0 
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pre-incubated in the presence of SM-1213, as well as in 
cell lysates from PEC-0 pre-incubated in the absence of 
drug and exposed to SM-1213 during the time of assay. 
NADPH-dependent killing of ~ albicans by PEC-0 homogenates 
was also increased by SM-1213. These data suggest that the 
observed increased candidacidal effects for drug-treated 
PEC-0 result in part from an enhancement of the NADPH-
dependent oxidative killing mechanisms of phagocytes and, 
more specifically, from drug enhancement of phagocyte 
NAD(P)H oxidase activity by mechanisms yet to be determined. 
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